Annual Statements Open main menu

TERADYNE, INC - Quarter Report: 2021 October (Form 10-Q)

Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 3, 2021
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
        
    
to
    
    
        
    
Commission File
No. 001-06462
 
 
TERADYNE, INC.
(Exact name of registrant as specified in its charter)
 
 
 
Massachusetts
 
04-2272148
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
600 Riverpark Drive, North Reading,
Massachusetts
 
01864
(Address of Principal Executive Offices)
 
(Zip Code)
978-370-2700
(Registrant’s Telephone Number, Including Area Code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.125 per share
 
TER
 
Nasdaq Stock Market LLC
 
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2
of the Exchange Act (check one):
 
Large accelerated filer      Accelerated filer  
Non-accelerated
filer
     Emerging growth company  
Smaller reporting company       
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No  ☒
The number of shares outstanding of the registrant’s only class of Common Stock as of November 1, 2021 was 163,004,340 shares.
 
 
 

Table of Contents
TERADYNE, INC.
INDEX
 
         
Page No.
 
     
Item 1.
   Financial Statements (Unaudited):   
   Condensed Consolidated Balance Sheets as of October 3, 2021 and December 31, 2020      1  
   Condensed Consolidated Statements of Operations for the Three and Nine Months Ended October 3, 2021 and September 27, 2020      2  
   Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended October 3, 2021 and September 27, 2020      3  
   Condensed Consolidated Statements of Shareholders’ Equity for the Three and Nine Months Ended October 3, 2021 and September 27, 2020      4  
   Condensed Consolidated Statements of Cash Flows for the Nine Months Ended October 3, 2021 and September 27, 2020      5  
   Notes to Condensed Consolidated Financial Statements      6  
Item 2.
   Management’s Discussion and Analysis of Financial Condition and Results of Operations      28  
Item 3.
   Quantitative and Qualitative Disclosures about Market Risk      38  
Item 4.
   Controls and Procedures      39  
     
Item 1.
   Legal Proceedings      39  
Item 1A.
   Risk Factors      39  
Item 2.
   Unregistered Sales of Equity Securities and Use of Proceeds      40  
Item 4.
   Mine Safety Disclosures      41  
Item 6.
   Exhibits      42  

Table of Contents
PART I
 
Item 1:
Financial Statements
TERADYNE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
 
 
  
October 3, 2021
 
  
December 31, 2020
 
 
  
 
 
  
 
 
 
  
(in thousands, except per share amount)
 
ASSETS
  
  
Current assets:
  
  
Cash and cash equivalents
  
$
1,079,454
 
  
$
914,121
 
Marketable securities
  
 
233,397
 
  
 
522,280
 
Accounts receivable, less allowance for credit losses of $1,913 and $2,034 at October 3, 2021 and December 31, 2020, respectively
  
 
597,124
 
  
 
497,506
 
Inventories, net
  
 
224,242
 
  
 
222,189
 
Prepayments and other current assets
  
 
386,967
 
  
 
259,338
 
    
 
 
    
 
 
 
Total current assets
  
 
2,521,184
 
  
 
2,415,434
 
Property, plant and equipment, net
  
 
390,545
 
  
 
394,800
 
Operating lease
right-of-use
assets, net
  
 
61,608
 
  
 
54,569
 
Marketable securities
  
 
136,664
 
  
 
117,980
 
Deferred tax assets
  
 
96,808
 
  
 
87,913
 
Retirement plans assets
  
 
16,958
 
  
 
17,468
 
Other assets
  
 
23,340
 
  
 
9,384
 
Acquired intangible assets, net
  
 
81,677
 
  
 
100,939
 
Goodwill
  
 
433,398
 
  
 
453,859
 
    
 
 
    
 
 
 
Total assets
  
$
3,762,182
 
  
$
3,652,346
 
    
 
 
    
 
 
 
LIABILITIES
  
 
 
 
  
 
 
 
Current liabilities:
  
 
 
 
  
 
 
 
Accounts payable
  
$
154,912
 
  
$
133,663
 
Accrued employees’ compensation and withholdings
  
 
196,928
 
  
 
220,321
 
Deferred revenue and customer advances
  
 
140,380
 
  
 
134,662
 
Other accrued liabilities
  
 
135,492
 
  
 
77,581
 
Operating lease liabilities
  
 
20,601
 
  
 
20,573
 
Income taxes payable
  
 
73,077
 
  
 
80,728
 
Current debt
  
 
32,219
 
  
 
33,343
 
    
 
 
    
 
 
 
Total current liabilities
  
 
753,609
 
  
 
700,871
 
Retirement plans liabilities
  
 
153,249
 
  
 
151,140
 
Long-term deferred revenue and customer advances
  
 
60,022
 
  
 
58,359
 
Long-term contingent consideration
  
 
  
 
  
 
7,227
 
Long-term other accrued liabilities
  
 
19,704
 
  
 
19,352
 
Deferred tax liabilities
  
 
6,907
 
  
 
10,821
 
Long-term operating lease liabilities
  
 
48,492
 
  
 
42,073
 
Long-term incomes taxes payable
  
 
67,041
 
  
 
74,930
 
Debt
  
 
112,784
 
  
 
376,768
 
    
 
 
    
 
 
 
Total liabilities
  
 
1,221,808
 
  
 
1,441,541
 
    
 
 
    
 
 
 
Commitments and contingencies
  
 
  
 
Mezzanine equity:
  
 
 
 
  
 
 
 
Convertible common shares
  
 
2,881
 
  
 
3,787
 
SHAREHOLDERS’ EQUITY
  
 
 
 
  
 
 
 
Common stock, $0.125 par value, 1,000,000 shares authorized; 163,728 and 166,123 shares issued and outstanding at October 3, 2021 and December 31, 2020, respectively
  
 
20,466
 
  
 
20,765
 
Additional
paid-in
capital
  
 
1,800,373
 
  
 
1,765,323
 
Accumulated other comprehensive income
  
 
4,217
 
  
 
33,516
 
Retained earnings
  
 
712,437
 
  
 
387,414
 
    
 
 
    
 
 
 
Total shareholders’ equity
  
 
2,537,493
 
  
 
2,207,018
 
    
 
 
    
 
 
 
Total liabilities, convertible common shares and shareholders’ equity
  
$
3,762,182
 
  
$
3,652,346
 
    
 
 
    
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2020, are an integral part of the condensed
consolidated financial statements.
 
1
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 
  
For the Three Months

Ended
 
 
For the Nine Months

Ended
 
 
  
October 3,
2021
 
 
September 27,
2020
 
 
October 3,
2021
 
 
September 27,
2020
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
(in thousands, except per share amount)
 
Revenues:
  
 
 
 
Products
   $ 825,448     $ 697,745     $ 2,437,901     $ 2,043,281  
Services
     125,053       121,739       379,934       319,219  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total revenues
     950,501       819,484       2,817,835       2,362,500  
Cost of revenues:
                                
Cost of products
     333,229       300,174       989,859       882,902  
Cost of services
     46,271       60,382       148,368       143,647  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)
     379,500       360,556       1,138,227       1,026,549  
    
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     571,001       458,928       1,679,608       1,335,951  
Operating expenses:
                                
Selling and administrative
     134,829       115,840       404,812       340,488  
Engineering and development
     107,220       94,909       317,644       274,170  
Acquired intangible assets amortization
     5,355       6,219       16,293       25,052  
Restructuring and other
     1,197       (27,701     (3,426     1,915  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     248,601       189,267       735,323       641,625  
    
 
 
   
 
 
   
 
 
   
 
 
 
Income from operations
     322,400       269,661       944,285       694,326  
Non-operating
(income) expense:
                                
Interest income
     (626     (1,071     (2,066     (5,189
Interest expense
     3,785       6,237       15,354       17,831  
Other (income) expense, net
     21,486       764       25,223       3,595  
    
 
 
   
 
 
   
 
 
   
 
 
 
Income before income taxes
     297,755       263,731       905,774       678,089  
Income tax provision
     41,037       41,013       115,225       90,274  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income
   $ 256,718     $ 222,718     $ 790,549     $ 587,815  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income per common share:
                                
Basic
   $ 1.56     $ 1.34     $ 4.77     $ 3.54  
    
 
 
   
 
 
   
 
 
   
 
 
 
Diluted
   $ 1.41     $ 1.21     $ 4.26     $ 3.23  
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares—basic
     164,583       166,014       165,690       166,131  
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares—diluted
     181,987       184,338       185,492       181,777  
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2020, are an integral part of the condensed
consolidated financial statements.
 
2

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 
 
  
For the Three Months

Ended
 
 
For the Nine Months

Ended
 
 
  
October 3,
2021
 
 
September 27,
2020
 
 
October 3,
2021
 
 
September 27,
2020
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
(in thousands)
 
Net income
   $ 256,718     $ 222,718     $ 790,549     $ 587,815  
Other comprehensive income, net of tax:
                                
Foreign currency translation adjustment, net of tax of $0, $0, $0, $0, respectively
     (10,698     17,104       (26,672     24,131  
Available-for-sale
marketable securities:
                                
Unrealized (losses) gains on marketable securities arising during period, net of tax of $(44), $139, $(516), and $1,410, respectively
     (176     335       (1,952     5,165  
Less: Reclassification adjustment for gains included in net income, net of tax of $(65), $(194), $(186), $(615), respectively
     (229     (689     (670     (2,188
    
 
 
   
 
 
   
 
 
   
 
 
 
       (405     (354     (2,622     2,977  
Defined benefit post-retirement plan:
                                
Amortization of prior service credit, net of tax of $0, $0, $(2), $(1), respectively
     (2     (2     (5     (6
    
 
 
   
 
 
   
 
 
   
 
 
 
Other comprehensive (loss) income
     (11,105     16,748       (29,299     27,102  
    
 
 
   
 
 
   
 
 
   
 
 
 
Comprehensive income
   $ 245,613     $ 239,466     $ 761,250     $ 614,917  
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2020, are an integral part of the condensed
consolidated financial statements.
 
3

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES
AND SHAREHOLDERS’ EQUITY
(Unaudited)
 
         
Shareholders’ Equity
 
   
Convertible
Common
Share
s

Value
   
Common
Stock
Shares
   
Common
Stock
Par
Value
   
Additional
Paid-in

Capital
   
Accumulated
Other
Comprehensive
Income (Loss)
   
Retained
Earnings
(Accumulated
Deficit)
   
Total
Shareholders’
Equity
 
                                           
         
(in thousands)
 
For the Three Months Ended October 3, 2021
                                                     
Balance, July 4, 2021
  $ 21,386       165,444     $ 20,680     $ 1,772,302     $ 15,322     $ 684,952     $ 2,493,256  
Net issuance of common stock under stock-based plans
            8       1       (259                     (258
Stock-based compensation expense
                            10,042                       10,042  
Repurchase of common stock
            (1,724     (215                     (212,781     (212,996
Cash dividends ($0.10 per share)
                                            (16,452     (16,452
Settlements of convertible notes
            5,589       699       636,798                       637,497  
Exercise of convertible notes hedge call options
            (5,589     (699     (637,015                     (637,714
Convertible common shares
    (18,505                     18,505                       18,505  
Net income
                                            256,718       256,718  
Other comprehensive loss
                                    (11,105             (11,105
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, October 3, 2021
  $ 2,881       163,728     $ 20,466     $ 1,800,373     $ 4,217     $ 712,437     $ 2,537,493  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
               
For the Three Months Ended September 27, 2020
                                                     
Balance, June 28, 2020
  $ —         165,806     $ 20,725     $ 1,730,716     $ (8,500   $ 1,610     $ 1,744,551  
Net issuance of common stock under stock-based plans
            237       30       13,515                       13,545  
Stock-based compensation expense
                            12,600                       12,600  
Cash dividends ($0.10 per share)
                                            (16,618     (16,618
Net income
                                            222,718       222,718  
Other comprehensive income
                                    16,748               16,748  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, September 27, 2020
  $ —         166,043     $ 20,755     $ 1,756,831     $ 8,248     $ 207,710     $ 1,993,544  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
               
For the Nine Months Ended October 3, 2021
                                                     
Balance, December 31, 2020
  $ 3,787       166,123     $ 20,765     $ 1,765,323     $ 33,516     $ 387,414     $ 2,207,018  
Net issuance of common stock under stock-based plans
            893       112       (48                     64  
Stock-based compensation expense
                            35,915                       35,915  
Repurchase of common stock
            (3,288     (411                     (415,769     (416,180
Cash dividends ($0.30 per share)
                                            (49,757     (49,757
Settlements of convertible notes
            7,178       897       840,305                       841,202  
Exercise of convertible notes hedge call options
            (7,178     (897     (842,028                     (842,925
Convertible common shares
    (906                     906                       906  
Net income
                                            790,549       790,549  
Other comprehensive loss
                                    (29,299             (29,299
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, October 3, 2021
  $ 2,881       163,728     $ 20,466     $ 1,800,373     $ 4,217     $ 712,437     $ 2,537,493  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
               
For the Nine Months Ended September 27, 2020
                                                     
Balance, December 31, 2019
  $ —         166,410     $ 20,801     $ 1,720,129     $ (18,854   $ (241,918   $ 1,480,158  
Net issuance of common stock under stock-based plans
            1,150       144       3,019                       3,163  
Stock-based compensation expense
                            33,683                       33,683  
Repurchase of common stock
            (1,517     (190                     (88,275     (88,465
Cash dividends ($0.30 per share)
                                            (49,912     (49,912
Net income
                                            587,815       587,815  
Other comprehensive income
                                    27,102               27,102  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, September 27, 2020
  $ —         166,043     $ 20,755     $ 1,756,831     $ 8,248     $ 207,710     $ 1,993,544  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2020, are an integral part of the condensed
consolidated financial statements.
 
4

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
    
For the Nine Months Ended
 
    
October 3,
2021
   
September 27,
2020
 
              
    
(in thousands)
 
Cash flows from operating activities:
                
Net income
   $ 790,549     $ 587,815  
Adjustments to reconcile net income from operations to net cash provided by operating activities:
                
Depreciation
     67,866       58,111  
Stock-based compensation
     34,649       33,028  
Amortization
     27,626       36,577  
Loss on convertible debt conversion
     25,397       —    
Provision for excess and obsolete inventory
     11,775       13,116  
Deferred taxes
     (10,732     (4,547
Contingent consideration adjustment
     (7,227     (7,967
Gains on investments
     (4,750     (3,515
Retirement plan actuarial (gains) losses
     (627     2,589  
Other
     243       750  
Changes in operating assets and liabilities, net of businesses acquired:
                
Accounts receivable
     (103,299     (222,015
Inventories
     21,943       16,998  
Prepayments and other assets
     (138,564     (40,751
Accounts payable and other liabilities
     65,064       81,557  
Deferred revenue and customer advances
     8,699       36,589  
Retirement plans contributions
     (4,123     (3,884
Income taxes
     (17,406     24,060  
    
 
 
   
 
 
 
Net cash provided by operating activities
     767,083       608,511  
    
 
 
   
 
 
 
Cash flows from investing activities:
                
Purchases of property, plant and equipment
     (103,162     (146,872
Purchases of marketable securities
     (509,470     (488,428
Proceeds from maturities of marketable securities
     571,277       309,407  
Proceeds from sales of marketable securities
     209,437       32,611  
Purchase of investment and acquisition of business
     (12,000     149  
Proceeds from life insurance
     —         546  
    
 
 
   
 
 
 
Net cash provided by (used for) investing activities
     156,082       (292,587
    
 
 
   
 
 
 
Cash flows from financing activities:
                
Issuance of common stock under stock purchase and stock option plans
     32,590       26,528  
Repurchase of common stock
     (406,180     (88,465
Payments of convertible debt principal
     (301,997     —    
Dividend payments
     (49,711     (49,870
Payments related to net settlement of employee stock compensation awards
     (32,045     (22,735
Payments of contingent consideration
     —         (8,852
    
 
 
   
 
 
 
Net cash used for financing activities
     (757,343     (143,394
    
 
 
   
 
 
 
Effects of exchange rate changes on cash and cash equivalents
     (489     (1,274
    
 
 
   
 
 
 
Increase in cash and cash equivalents
     165,333       171,256  
Cash and cash equivalents at beginning of period
     914,121       773,924  
    
 
 
   
 
 
 
Cash and cash equivalents at end of period
   $ 1,079,454     $ 945,180  
    
 
 
   
 
 
 
Non-cash
investing activities:
                
Capital expenditures incurred but not yet paid:
   $ 2,286     $ 3,119  
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2020, are an integral part of the condensed
consolidated financial statements.
 
5

TERADYNE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A. THE COMPANY
Teradyne, Inc. (“Teradyne”) is a leading global supplier of automation equipment for test and industrial applications. Teradyne designs, develops, manufactures and sells automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s industrial automation products include collaborative robotic arms, autonomous mobile robots, and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Teradyne’s automatic test equipment and industrial automation products and services include:
 
   
semiconductor test (“Semiconductor Test”) systems;
 
   
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
 
   
wireless test (“Wireless Test”) systems; and
 
   
industrial automation (“Industrial Automation”) products.
B. ACCOUNTING POLICIES
Basis of Presentation
The consolidated interim financial statements include th
e
 accounts of Teradyne and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. Certain prior year amounts were reclassified to conform to the current year presentation. The December 31, 2020 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by United States of America generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form
10-K,
filed with the U.S. Securities and Exchange Commission (“SEC”) on February 22, 2021, for the year ended December 31, 2020.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent liabilities. On an
on-going
basis, management evaluates its estimates, including those related to inventories, investments, goodwill, intangible and other long-lived assets, accounts receivable, income taxes, deferred tax assets and liabilities, pensions, warranties, contingent consideration liabilities, and loss contingencies. Management bases its estimates on historical experience and on appropriate and customary assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent from other sources. Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. Management is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of November 5, 2021, the date of issuance of this Quarterly Report on Form
10-Q.
These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.
C. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06
– “Debt—Debt with Conversion and Other Options and Derivatives and Hedging - Contracts in Entity’s Own Equity,” which simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. This ASU requires a convertible debt instrument to be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. This ASU requires an entity to use the
if-converted
method in the diluted earnings per share calculation for convertible instruments. This ASU will be effective for Teradyne on January 1, 2022. This ASU permits the use of either the modified retrospective or fully retrospective method of transition. Teradyne is evaluating the effects of the adoption of this ASU on its financial statements.
On November 
4
, 2021, Teradyne made an irrevocable election under the indenture entered into between Teradyne and Wilmington Trust, National Association, as trustee (the “Indenture”) for the issuance of the 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023 to require the principal portion of the remaining Notes to be settled in cash. Upon adoption of ASU
2020-06,
only the amounts settled in excess of the principal will be considered in diluted earnings per share under the
if-converted
method.
 
6

D. INVESTMENT IN OTHER COMPANY
On June
 1, 2021, Teradyne invested $12.0 million in MachineMetrics, Inc. (“MachineMetrics”), a private company that develops and sells products to improve manufacturing performance through automated machine data collection, alerting, and analytics. Teradyne’s investment in MachineMetrics aligns with its strategy of providing and investing in leading edge products for automating industrial production processes in growing markets. The investment was recorded at cost and is evaluated for impairment or an indication of changes in fair value resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer on a quarterly basis. At October 3, 2021, the value of the investment was $12.0 million, and there was no change during the three months ended October 3, 2021.
E. REVENUE
Disaggregation of Revenue
The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.
 
 
 
Semiconductor Test
 
 
 
 
 
Industrial Automation
 
 
 
 
 
 
 
 
 
 
 
 
System
on-a-Chip
 
 
Memory
 
 
System

Test
 
 
Universal
Robots
 
 
Mobile
Industrial
Robots
 
 
AutoGuide
 
 
Wireless

Test
 
 
Corporate

and

Other
 
 
Total
 
 
 
(in thousands)
 
For the Three Months Ended October 3, 2021 (1)
 
 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
 
 
Point in Time
 
$
508,747
 
 
$
105,454
 
 
$
88,155
 
 
$
76,008
 
 
$
12,351
 
 
$
226
 
 
$
65,409
 
 
$
(63
 
$
856,287
 
Over Time
 
 
66,270
 
 
 
7,761
 
 
 
14,450
 
 
 
1,742
 
 
 
607
 
 
 
80
 
 
 
3,304
 
 
 
—  
 
 
 
94,214
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
575,017
 
 
$
113,215
 
 
$
102,605
 
 
$
77,750
 
 
$
12,958
 
 
$
306
 
 
$
68,713
 
 
$
(63
 
$
950,501
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
                                                                       
Asia Pacific
 
$
519,886
 
 
$
110,362
 
 
$
62,757
 
 
$
19,654
 
 
$
2,788
 
 
$
—  
 
 
$
54,344
 
 
$
—  
 
 
$
769,791
 
Americas
 
 
29,119
 
 
 
2,281
 
 
 
34,560
 
 
 
23,429
 
 
 
5,015
 
 
 
306
 
 
 
11,352
 
 
 
(63
 
 
105,999
 
Europe, Middle East and Africa
 
 
26,012
 
 
 
572
 
 
 
5,288
 
 
 
34,667
 
 
 
5,155
 
 
 
—  
 
 
 
3,017
 
 
 
—  
 
 
 
74,711
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
575,017
 
 
$
113,215
 
 
$
102,605
 
 
$
77,750
 
 
$
12,958
 
 
$
306
 
 
$
68,713
 
 
$
(63
 
$
950,501
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the Three Months Ended September 27, 2020 (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Point in Time
 
$
393,717
 
 
$
137,929
 
 
$
101,045
 
 
$
51,523
 
 
$
10,175
 
 
$
4,076
 
 
$
37,901
 
 
$
(41
 
$
736,325
 
Over Time
 
 
55,988
 
 
 
4,507
 
 
 
17,124
 
 
 
1,686
 
 
 
59
 
 
 
1,192
 
 
 
2,603
 
 
 
—  
 
 
 
83,159
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
449,705
 
 
$
142,436
 
 
$
118,169
 
 
$
53,209
 
 
$
10,234
 
 
$
5,268
 
 
$
40,504
 
 
$
(41
 
$
819,484
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asia Pacific
 
$
420,821
 
 
$
137,286
 
 
$
78,534
 
 
$
14,471
 
 
$
1,566
 
 
$
—  
 
 
$
33,865
 
 
$
—  
 
 
$
686,543
 
Americas
 
 
17,678
 
 
 
3,730
 
 
 
35,140
 
 
 
16,527
 
 
 
3,981
 
 
 
5,268
 
 
 
5,211
 
 
 
(41
 
 
87,494
 
Europe, Middle East and Africa
 
 
11,206
 
 
 
1,420
 
 
 
4,495
 
 
 
22,211
 
 
 
4,687
 
 
 
—  
 
 
 
1,428
 
 
 
—  
 
 
 
45,447
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
449,705
 
 
$
142,436
 
 
$
118,169
 
 
$
53,209
 
 
$
10,234
 
 
$
5,268
 
 
$
40,504
 
 
$
(41
 
$
819,484
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the Nine Months Ended October 3, 2021 (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Point in Time
 
$
1,548,895
 
 
$
291,578
 
 
$
295,666
 
 
$
214,427
 
 
$
41,506
 
 
$
106
 
 
$
154,908
 
 
$
(352
 
$
2,546,734
 
Over Time
 
 
188,022
 
 
 
21,776
 
 
 
44,595
 
 
 
5,001
 
 
 
1,483
 
 
 
628
 
 
 
9,596
 
 
 
—  
 
 
 
271,101
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
1,736,917
 
 
$
313,354
 
 
$
340,261
 
 
$
219,428
 
 
$
42,989
 
 
$
734
 
 
$
164,504
 
 
$
(352
 
$
2,817,835
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
                                                                       
Asia Pacific
 
$
1,618,117
 
 
$
301,562
 
 
$
223,507
 
 
$
55,531
 
 
$
8,674
 
 
$
—  
 
 
$
133,678
 
 
$
—  
 
 
$
2,341,069
 
Americas
 
 
71,562
 
 
 
9,373
 
 
 
98,475
 
 
 
66,390
 
 
 
17,065
 
 
 
734
 
 
 
24,228
 
 
 
(352
 
 
287,475
 
Europe, Middle East and Africa
 
 
47,238
 
 
 
2,419
 
 
 
18,279
 
 
 
97,507
 
 
 
17,250
 
 
 
—  
 
 
 
6,598
 
 
 
—  
 
 
 
189,291
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
1,736,917
 
 
$
313,354
 
 
$
340,261
 
 
$
219,428
 
 
$
42,989
 
 
$
734
 
 
$
164,504
 
 
$
(352
 
$
2,817,835
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the Nine Months Ended September 27, 2020 (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Point in Time
 
$
1,261,468
 
 
$
298,150
 
 
$
259,498
 
 
$
140,829
 
 
$
30,468
 
 
$
8,608
 
 
$
125,304
 
 
$
(294
 
$
2,124,031
 
Over Time
 
 
162,159
 
 
 
14,000
 
 
 
46,553
 
 
 
5,628
 
 
 
176
 
 
 
2,083
 
 
 
7,870
 
 
 
—  
 
 
 
238,469
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
1,423,627
 
 
$
312,150
 
 
$
306,051
 
 
$
146,457
 
 
$
30,644
 
 
$
10,691
 
 
$
133,174
 
 
$
(294
 
$
2,362,500
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asia Pacific
 
$
1,330,463
 
 
$
296,679
 
 
$
197,208
 
 
$
39,665
 
 
$
4,391
 
 
$
—  
 
 
$
113,576
 
 
$
—  
 
 
$
1,981,982
 
Americas
 
 
51,315
 
 
 
11,481
 
 
 
91,924
 
 
 
42,634
 
 
 
9,836
 
 
 
10,691
 
 
 
15,253
 
 
 
(294
 
 
232,840
 
Europe, Middle East and Africa
 
 
41,849
 
 
 
3,990
 
 
 
16,919
 
 
 
64,158
 
 
 
16,417
 
 
 
—  
 
 
 
4,345
 
 
 
—  
 
 
 
147,678
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
 
$
1,423,627
 
 
$
312,150
 
 
$
306,051
 
 
$
146,457
 
 
$
30,644
 
 
$
10,691
 
 
$
133,174
 
 
$
(294
 
$
2,362,500
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes $3.8 million and $1.7 million in 2021 and 2020, respectively, for leases of Teradyne’s systems recognized outside Accounting Standards Codification (“ASC”) 606
“Revenue from Contracts with Customers.”
(2)
Includes $11.1 million and $6.1 million in 2021 and 2020, respectively, for leases of Teradyne’s systems recognized outside ASC 606 “
Revenue from Contracts with Customers
.”
 
7
Contract Balances
During the three and nine months ended October 3, 2021, Teradyne recognized $32.9 million and $82.5 million, respectively, that was previously included within the deferred revenue and customer advances balances at the beginning of the period. During the three and nine months ended September 27, 2020, Teradyne recognized $17.6 million and $78.2 million, respectively, that was previously included within the deferred revenue and customer advances balances at the beginning of the period. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. As of October 3, 2021, Teradyne has $1,293.0 million of unsatisfied performance obligations. Teradyne expects to recognize 94% of the remaining performance obligations in the next 12 months, 5% in
1-3
years and 1% beyond 3 years.
Accounts Receivable
Teradyne sells certain trade accounts receivables on a
non-recourse
basis to third-party financial institutions pursuant to factoring agreements. Teradyne accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the consolidated statements of cash flows. Total trade accounts receivable sold under the factoring agreements were $66.9 million and $16.5 million for the three months ended October 3, 2021 and September 27, 2020, respectively, and $81.7 million and $113.5 million for the nine months ended October 3, 2021 and September 27, 2020, respectively. Factoring fees for the sales of receivables were recorded in interest expense and were not material.
F. INVENTORIES
Inventories, net consisted of th
e
 following at October 3, 2021 and December 31, 2020:
 
 
  
October 3,

2021
 
  
December 31,

2020
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Raw material
   $ 131,807      $ 114,133  
Work-in-process
     34,911        25,408  
Finished goods
     57,524        82,648  
    
 
 
    
 
 
 
     $ 224,242      $ 222,189  
    
 
 
    
 
 
 
Inventory reserves at October 3, 2021 and December 31, 2020 were $112.5 million and $110.6 million, respectively.
G. FINANCIAL INSTRUMENTS
Cash Equivalents
Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.
Marketable Securities
Teradyne’s
available-for-sale
debt securities are classified as Level 2 and equity and debt mutual funds are classified as Level 1. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.
During the three and nine months ended October 3, 2021 and September 27, 2020, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.
Realized gains recorded in the three and nine months ended October 3, 2021 were $0.5 million and $2.6 million, respectively. Realized gains recorded in the three and nine months ended September 27, 2020 were $1.1 million and $4.1 million, respectively. No realized losses were recorded in the three and nine months ended October 3, 2021. Realized losses recorded in the three and nine months ended September 27, 2020 were $0.1 million and $0.3 million, respectively. Realized gains and losses are included in other (income) expense, net.
Unrealized gains on equity securities recorded in the nine months ended October 3, 2021 were $3.3 million. Unrealized losses on equity securities recorded in the three and nine months ended October 3, 2021 were $0.4 million and $1.1 million, respectively. Unrealized gains on equity securities recorded in the three and nine months ended September 27, 2020 were $2.0 million and $5.7 million, respectively. Unrealized losses on equity securities recorded in the nine months ended September 27, 2020 were $6.0 million. Unrealized gains and losses on equity securities are included in other (income) expense, net. Unrealized gains and losses on
available-for-sale
debt securities are included in accumulated other comprehensive income.
The cost of securities sold is based on average cost.
 
8

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of October 3, 2021 and December 31, 2020.
 
 
  
October 3, 2021
 
 
  
Quoted Prices

in Active

Markets for

Identical

Instruments

(Level 1)
 
  
Significant

Other

Observable

Inputs

(Level 2)
 
  
Significant

Unobservable

Inputs

(Level 3)
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
  
  
  
Cash
   $ 577,752      $ —        $ —        $ 577,752  
Cash equivalents
     176,703        324,999        —          501,702  
Available-for-sale
securities:
                                   
Commercial paper
     —          179,629        —          179,629  
U.S. Treasury securities
     —          80,519        —          80,519  
Corporate debt securities
     —          58,648        —          58,648  
Debt mutual funds
     8,937        —          —          8,937  
U.S. government agency securities
     —          4,616        —          4,616  
Certificates of deposit and time deposits
     —          1,346        —          1,346  
Non-U.S.
government securities
     —          590        —          590  
Equity securities:
                                   
Mutual funds
     35,776        —          —          35,776  
    
 
 
    
 
 
    
 
 
    
 
 
 
     $ 799,168      $ 650,347      $ —        $ 1,449,515  
Derivative assets
     —          93        —          93  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 799,168      $ 650,440      $ —        $ 1,449,608  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Derivative liabilities
     —          433        —          433  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 433      $ —        $ 433  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Reported as follows:                                    
    
(Level 1)
    
(Level 2)
    
(Level 3)
    
Total
 
                             
    
(in thousands)
 
Assets
                                   
Cash and cash equivalents
   $ 754,455      $ 324,999      $ —        $ 1,079,454  
Marketable securities
     —          233,397        —          233,397  
Long-term marketable securities
     44,713        91,951        —          136,664  
Prepayments and other current assets
     —          93        —          93  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 799,168      $ 650,440      $ —        $ 1,449,608  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Other current liabilities
   $ —        $ 433      $ —        $ 433  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 433      $ —        $ 433  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
9

 
 
  
December 31, 2020
 
 
  
Quoted Prices

in Active

Markets for

Identical

Instruments

    (Level 1)    
 
  
Significant

Other

Observable

Inputs

    (Level 2)    
 
  
Significant

Unobservable

Inputs

    (Level 3)    
 
  
    Total    
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
  
  
  
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Cash
   $ 443,166      $ —        $ —        $ 443,166  
Cash equivalents
     347,768        123,187        —          470,955  
Available-for-sale
securities:
                                —    
U.S. Treasury securities
     —          258,304        —          258,304  
Commercial paper
     —          254,413        —          254,413  
Corporate debt securities
     —          83,615        —          83,615  
Debt mutual funds
     8,565        —          —          8,565  
U.S. government agency securities
     —          4,339        —          4,339  
Certificates of deposit and time deposits
     —          979        —          979  
Non-U.S.
government securities
     —          625        —          625  
Equity securities:
                                   
Equity mutual funds
     29,420        —          —          29,420  
    
 
 
    
 
 
    
 
 
    
 
 
 
     $ 828,919      $ 725,462      $      $ 1,554,381  
Derivative assets
     —          95        —          95  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 828,919      $ 725,557      $ —        $ 1,554,476  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Contingent consideration
   $ —        $ —        $ 7,227      $ 7,227  
Derivative liabilities
     —          504        —          504  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 504      $ 7,227      $ 7,731  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Reported as follows:
                                   
    
    (Level 1)    
    
    (Level 2)    
    
    (Level 3)    
    
    Total    
 
                             
    
(in thousands)
 
Assets
                                   
Cash and cash equivalents
   $ 790,934      $ 123,187      $ —        $ 914,121  
Marketable securities
     —          522,280        —          522,280  
Long-term marketable securities
     37,985        79,995        —          117,980  
Prepayments and other current assets
     —          95        —          95  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 828,919      $ 725,557      $ —        $ 1,554,476  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Other accrued liabilities
   $ —        $ 504      $ —        $ 504  
Long-term contingent consideration
     —          —          7,227        7,227  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 504      $ 7,227      $ 7,731  
    
 
 
    
 
 
    
 
 
    
 
 
 
Changes in the fair value of Level 3 contingent consideration for the three and nine months ended October 3, 2021 and September 27, 2020 were as follows:
 
 
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
 
  
(in thousands)
 
Balance at beginning of period
   $ —        $ 49,737      $ 7,227      $ 39,705  
Fair value adjustment (a)(b)(c)
     —          (27,206      (7,227      (7,967
Foreign currency impact
     —          —          —          (355
Payments (d)
     —          —          —          (8,852
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ —        $ 22,531      $ —        $ 22,531  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(a)
In the nine months ended October 3, 2021, the fair value of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide was reduced to zero, which resulted in a benefit of $7.2 million, primarily due to a decrease in forecasted revenues and earnings before interest and taxes. As of October 3, 2021, the maximum amount of contingent consideration that could be paid in connection with the acquisition of AutoGuide is $100.2 million. The remaining
earn-out
periods end on December 31, 2021 and December 31, 2022. The sellers of AutoGuide have filed an arbitration claim against Teradyne related to allegations of
non-compliance
with its
earn-out
obligations. The ultimate amount of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide may be affected by the outcome of the arbitration (see Note R: “Commitments and Contingencies”).
(b)
In the three and nine months ended September 27, 2020, the fair value of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide decreased by $27.2 million and $4.4 million, respectively, due to lower forecasted revenues and earnings before interest and taxes.
(c)
In the nine months ended September 27, 2020, the fair value of contingent consideration for the earn-outs in connection with the acquisition of Mobile Industrial Robots (“MiR”) decreased by $3.5 million due to lower forecasted results.
(d)
In the nine months ended September 27, 2020, Teradyne paid $8.9 million of contingent consideration for the
earn-out
in connection with the acquisition of MiR.
The carrying amounts and fair values of Teradyne’s financial instruments at October 3, 2021 and December 31, 2020 were as follows:
 
 
  
October 3, 2021
 
  
December 31, 2020
 
 
  
  Carrying Value  
 
  
  Fair Value  
 
  
  Carrying Value  
 
  
  Fair Value  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
     
  
     
  
     
  
     
Cash and cash equivalents
   $ 1,079,454      $ 1,079,454      $ 914,121      $ 914,121  
Marketable securities
     370,061        370,061        640,260        640,260  
Derivative assets
     93        93        95        95  
Liabilities
                                   
Contingent consideration
     —          —          7,227        7,227  
Derivative liabilities
     433        433        504        504  
Convertible debt (1)
     145,003        546,464        410,111        1,739,553  
 
(1)
The carrying value represents the bifurcated debt component only, while the level 2 fair value is based on quoted market prices for the convertible note, which includes the equity conversion features.
The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.
 
11

The following table summarizes the composition of
available-for-sale
marketable securities at October 3, 2021:
 
 
  
October 3, 2021
 
 
  
Available-for-Sale
 
  
 
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
Commercial paper
   $ 179,624      $ 5      $ —       $ 179,629      $ 20,799  
U.S. Treasury securities
     80,370        636        (487     80,519        17,336  
Corporate debt securities
     53,329        5,421        (102     58,648        22,010  
Debt mutual funds
     8,872        65        —         8,937        —    
U.S. government agency securities
     4,610        11        (5     4,616        3,302  
Certificates of deposit and time deposits
     1,346        —          —         1,346        —    
Non-U.S.
government securities
     590        —          —         590        —    
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 328,741      $ 6,138      $ (594   $ 334,285      $ 63,447  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
Reported as follows:
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
Marketable securities
   $ 233,327      $ 92      $ (22   $ 233,397      $ 28,773  
Long-term marketable securities
     95,414        6,046        (572     100,888        34,674  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 328,741      $ 6,138      $ (594   $ 334,285      $ 63,447  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
The following table summarizes the composition of
available-for-sale
marketable securities at December 31, 2020:
 
 
  
December 31, 2020
 
 
  
Available-for-Sale
 
  
 
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
U.S. Treasury securities
   $ 257,132      $ 1,330      $ (158   $ 258,304      $ 17,243  
Commercial paper
     254,404        10        (1     254,413        12,173  
Corporate debt securities
     76,129        7,539        (53     83,615        39,896  
Debt mutual funds
     8,413        152        —         8,565        —    
U.S. government agency securities
     4,294        46        (1     4,339        1,106  
Certificates of deposit and time deposits
     979        —          —         979        —    
Non-U.S.
government securities
     625        —          —         625        —    
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 601,976      $ 9,077      $ (213   $ 610,840      $ 70,418  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
Reported as follows:
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
Marketable securities
   $ 522,228      $ 92      $ (40   $ 522,280      $ 61,806  
Long-term marketable securities
     79,748        8,985        (173     88,560        8,612  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 601,976      $ 9,077      $ (213   $ 610,840      $ 70,418  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
12

As of October 3, 2021 and December 31, 2020, the fair market value of investments with unrealized losses less than one year totaled $57.3 million and $70.4 million, respectively. As of October 3, 2021, the fair market value of investments with unrealized losses for greater than one year totaled $6.2 million.
Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at October 3, 2021 and December 31, 2020 were not other than temporary.
The contractual maturities of investments in
available-for-sale
securities held at October 3, 2021 were as follows:
 
 
  
October 3, 2021
 
 
  
Cost
 
  
Fair Market

Value
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Due within one year
   $ 233,327      $ 233,397  
Due after 1 year through 5 years
     46,460        46,744  
Due after 5 years through 10 years
     6,120        6,586  
Due after 10 years
     33,962        38,621  
    
 
 
    
 
 
 
Total
   $ 319,869      $ 325,348  
    
 
 
    
 
 
 
Contractual maturities of investments in
available-for-sale
securities held at October 3, 2021 exclude debt mutual funds with a fair market value of $8.9 million, as they do not have a contractual maturity date.
Derivatives
Teradyne conducts business in a number of foreign countries with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.
To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.
The notional amount of foreign currency forward contracts at October 3, 2021 and December 31, 2020 was $181.8 million and $152.9 million, respectively.
Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.
The following table summarizes the fair value of derivative instruments as of October 3, 2021 and December 31, 2020:
 
 
  
Balance Sheet

Location
 
  
October 3,
2021
 
  
December 31,
2020
 
 
  
 
 
  
 
 
  
 
 
 
  
 
 
  
(in thousands)
 
Derivatives not designated as hedging instruments:
  
  
  
Foreign exchange contracts
     Prepayments      $ 93      $ 95  
Foreign exchange contracts
     Other current liabilities        (433      (504
             
 
 
    
 
 
 
Total derivatives
            $ (340    $ (409
             
 
 
    
 
 
 
The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three and nine months ended October 3, 2021 and September 27, 2020:
 
 
  
Location of Losses (Gains)

Recognized in

Statement of Operations
 
  
For the Three Months

Ended
 
 
For the Nine Months

Ended
 
 
  
October 3,

2021
 
  
September 27,

2020
 
 
October 3,

2021
 
  
September 27,

2020
 
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
 
 
  
(in thousands)
 
Derivatives not designated as hedging instruments:
                                           
Foreign exchange contracts
     Other (income) expense, net      $ 2,288      $ (551   $ 5,937      $ 3,930  
 
13

 
(1)
The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies.
(2)
For the three and nine months ended October 3, 2021, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $1.0 million and $1.3 million, respectively.
(3)
For the three months ended September 27, 2020, net losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $1.2 million. For the nine months ended September 27, 2020, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.4 million.
See Note H: “Debt” regarding derivatives related to the convertible senior notes.
H. DEBT
Convertible Senior Notes
On December 12, 2016, Teradyne completed a private offering of $460.0 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023 and received net proceeds, after issuance costs, of approximately $450.8 million, $33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s common stock under its existing stock repurchase program from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bear interest from December 12, 2016 at a rate of 1.25% per year payable semiannually in arrears on June 15 and December 15 of each year. The Notes will be convertible at the option of the noteholders at any time prior to the close of business on the business day immediately preceding September 15, 2023, only under the following circumstances: (1) during any calendar quarter beginning after March 31, 2017 (and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price (as defined in the indenture dated as of December 12, 2016 between Teradyne and Wilmington Trust, National Association, as trustee (the “Indenture”)) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the closing sale price of the Teradyne’s common stock and the conversion rate on each such trading day; and (3) upon the occurrence of specified corporate events. On or after September 15, 2023 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its conversion obligation by paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election. As of October 3, 2021, the conversion price was approximately $31.53 per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances. As of November 5, 2021, seventy-
nine
holders had exercised the option to convert $343.0 million worth of Notes. On November 
4
, 2021, Teradyne made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash.
Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.53. The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, approximately 8.7 million shares of Teradyne’s common stock.
Separately and concurrent with the pricing of the Notes, Teradyne entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which it sold
net-share-settled
(or, at its election subject to certain conditions, cash-settled) warrants to the Option Counterparties. The Warrant Transactions currently cover, subject to customary anti-dilution adjustments, approximately 14.6 million shares of common stock. As of October 3, 2021, the strike price of the warrants was approximately $39.56 per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect to Teradyne’s common stock to the extent that the market price per share of Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.
The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0 million.
In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option
 
14

Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.
Teradyne considered the guidance of ASC
815-40,
“Derivatives and Hedging—Contracts in Entity’s Own Equity,”
and concluded that the convertible note hedge is both indexed to Teradyne’s common stock and should be classified in stockholders’ equity in its statements of financial position. The convertible note hedge is considered indexed to Teradyne’s common stock as the terms of the Note Hedge Transactions do not contain an exercise contingency and the settlement amount equals the difference between the fair value of a fixed number of Teradyne’s shares and a fixed strike price. Because the only variable that can affect the settlement amount is Teradyne’s stock price, which is an input to the fair value of a
fixed-for-fixed
option contract, the convertible note hedge is considered indexed to Teradyne’s common stock.
Teradyne assessed whether the convertible note hedge should be classified as equity under ASC
815-40.
In the Note Hedge Transactions contract the settlement terms permit net cash settlement or net share settlement, at the option of Teradyne. Therefore, the criteria as set forth in ASC
815-40
were evaluated by Teradyne. In reviewing the criteria, Teradyne noted the following: (1) the convertible note hedge does not require Teradyne to issue shares; (2) there is no requirement to net cash settle the convertible note hedge for failure to make timely filings with the SEC; (3) in the case of termination, the convertible note hedge is settled in the same consideration as the holders of the underlying stock; (4) the counterparty does not have rights that rank higher than those of a shareholder of the stock underlying the convertible note hedge; and (5) there is no requirement to post collateral. Based on its analysis of those criteria, Teradyne concluded that the convertible note hedge should be recorded in equity and no further adjustment should be made in future periods to adjust the value of the convertible note hedge.
Teradyne analyzed the Warrant Transactions under ASC
815-40,
“Derivatives and Hedging—Contracts in Entity’s Own Equity,”
and other relevant literature, and determined that it met the criteria for classification as an equity transaction and is considered indexed to Teradyne’s common stock. As a result, Teradyne recorded the proceeds from the warrants as an increase to additional
paid-in
capital. Teradyne does not recognize subsequent changes in fair value of the warrants in its financial statements.
The provisions of ASC
470-20,
Debt with Conversion and Other Options,
” are applicable to the Notes. ASC
470-20
requires Teradyne to separately account for the liability (debt) and equity (conversion feature) components of the Notes in a manner that reflects Teradyne’s nonconvertible debt borrowing rate at the date of issuance when interest cost is recognized in subsequent periods. Teradyne allocated $100.8 million of the $460.0 million principal amount of the Notes to the equity component, which represents a discount to the debt and will be amortized to interest expense using the effective interest method through December 2023. Accordingly, Teradyne’s effective annual interest rate on the Notes will be approximately 5.0%. The Notes are classified as long-term debt in the balance sheet based on their December 15, 2023 maturity date, except for the conversions that occurred during the third quarter of 2021, which are included in current debt. Debt issuance costs of approximately $7.2 million initially are amortized to interest expense using the effective interest method over the seven-year term of the Notes. As of October 3, 2021, unamortized debt issuance costs were approximately $0.9 million.
The below tables represent the key components of Teradyne’s convertible senior notes:
 
 
  
October 3,

2021
 
  
December 31,
2020
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Debt principal
   $ 157,972      $ 459,971  
Unamortized discount
     12,969        49,860  
    
 
 
    
 
 
 
Net Carrying amount of convertible debt
   $ 145,003      $ 410,111  
    
 
 
    
 
 
 
Reported as follows:
 
 
  
October 3,

2021
 
  
December 31,
2020
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Current debt
   $ 32,219      $ 33,343  
Long-term debt
     112,784        376,768  
    
 
 
    
 
 
 
Net carrying amount of convertible debt
   $ 145,003      $ 410,111  
    
 
 
    
 
 
 
 
15

 
 
  
For the Three Months Ended
 
  
For the Nine Months Ended
 
 
  
October 3,

2021
 
  
September 27,

2020
 
  
October 3,

2021
 
  
September 27,

2020
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Contractual interest expense on the coupon
   $ 355      $ 1,438      $ 2,666      $ 4,313  
Amortization of the discount component and debt issue fees recognized as interest expense
     2,424        3,887        9,771        11,518  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total interest expense on the convertible debt
   $ 2,779      $ 5,325      $ 12,437      $ 15,831  
    
 
 
    
 
 
    
 
 
    
 
 
 
As of October 3, 2021, the remaining unamortized discount was $13.0 million, which will be amortized over 2.3 years using the effective interest rate method. The carrying amount of the equity component was $100.8 million.
As of October 3, 2021, the conversion price was approximately $31.53 per share and the
if-converted
value of the notes was $1,364.6 million.
During the three and nine months ended October 3, 2021, certain debt holders elected to convert $235.2 million and $302.0 million, respectively, of debt principal. The conversions in the three and nine months ended October 3, 2021 resulted in a loss of $20.2 million and $25.4 million, respectively, recorded to other (income) expense, net in the consolidated statement of operations. The conversion of the debt was settled in cash for principal amount and in shares for the excess of conversion value over principal amount. The 7.2 million shares issued to the debt holders were received from exercising the convertible notes hedge call options.
Additional conversions of approximately $41.0 million of debt principal will occur in the fourth quarter of 2021. The liability component is included in current debt and the equity component is included in convertible common shares.
Revolving Credit Facility
On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provides for a three-year, senior secured revolving credit facility of $400.0 million (the “Credit Facility”). The Credit Agreement further provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders incremental commitments under the Credit Facility in an aggregate principal amount not to exceed $150.0 million.
Proceeds from the Credit Facility may be used for general corporate purposes and working capital. Teradyne incurred $3.5 million in costs related to the revolving credit facility. These costs are being amortized over the three-year term of the revolving credit facility and are included in interest expense in the statement of operations. As of November 5, 2021, Teradyne has not borrowed any funds under the Credit Facility.
The interest rates applicable to loans under the Credit Facility are, at Teradyne’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.25% per annum or LIBOR, a minimum of 0.75%, plus a margin ranging from 1.50% to 2.25% per annum, based on the consolidated leverage ratio of Teradyne. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.25% to 0.40% per annum, based on the then applicable consolidated leverage ratio.
Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary LIBOR breakage costs.
The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter: a consolidated leverage ratio and an interest coverage ratio.
The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries.
As of November 5, 2021, Teradyne was in compliance with all covenants.
 
16

I. PREPAYMENTS
Prepayments consist of the following and are included in prepayments and other assets on the balance sheet:
 
 
  
October 3,
2021
 
  
December 31,
2020
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Contract manufacturer and supplier prepayments
   $ 334,660      $ 212,286  
Prepaid maintenance and other services
     13,574        13,116  
Prepaid taxes
     13,822        9,361  
Other prepayments
     12,093        15,329  
    
 
 
    
 
 
 
Total prepayments
   $ 374,149      $ 250,092  
    
 
 
    
 
 
 
J. DEFERRED REVENUE AND CUSTOMER ADVANCES
Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:
 
 
  
October 3,
2021
 
  
December 31,
2020
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Maintenance, service and training
   $ 83,046      $ 77,654  
Extended warranty
     67,482        51,929  
Customer advances, undelivered elements and other
     49,874        63,438  
    
 
 
    
 
 
 
Total deferred revenue and customer advances
   $ 200,402      $ 193,021  
    
 
 
    
 
 
 
K. PRODUCT WARRANTY
Teradyne generally provides a
one-year
warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities.
 
 
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Balance at beginning of period
   $ 25,676      $ 13,016      $ 16,633      $ 8,996  
Accruals for warranties issued during the period
     6,641        8,255        28,719        19,522  
Accruals related to
pre-existing
warranties
     (963      158        (3,966      1,569  
Settlements made during the period
     (5,233      (6,272      (15,265      (14,930
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ 26,121      $ 15,157      $ 26,121      $ 15,157  
    
 
 
    
 
 
    
 
 
    
 
 
 
When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances.
 
 
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Balance at beginning of period
   $ 63,525      $ 40,178      $ 51,929      $ 30,677  
Deferral of new extended warranty revenue
     12,728        13,674        36,533        32,724  
Recognition of extended warranty deferred revenue
     (8,771      (5,149      (20,980      (14,698
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ 67,482      $ 48,703      $ 67,482      $ 48,703  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
17

L. STOCK-BASED COMPENSATION
Under Teradyne’s stock compensation plans, Teradyne grants service-based restricted stock units, performance-based restricted stock units and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).
Service-based restricted stock unit awards granted to employees vest in equal annual installments over four years. Restricted stock unit awards granted to
non-employee
directors vest after a
one-year
period, with 100% of the award vesting on the earlier of (a) the first anniversary of the grant date or (b) the date of the following year’s annual meeting of shareholders. Teradyne expenses the cost of the restricted stock unit awards subject to service-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.
Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.
PRSUs granted to Teradyne’s executive officers may also have a performance metric based on three-year cumulative
non-GAAP
profit before interest and tax (“PBIT”) as a percent of Teradyne’s revenue.
Non-GAAP
PBIT is a financial measure equal to GAAP income from operations less restructuring and other, net; amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses;
non-cash
convertible debt interest expense; and other
non-recurring
gains and charges. The final number of PBIT PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the retirement and termination eligibility provisions noted below.
If a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period.
Stock options to purchase Teradyne’s common stock at 100% of the fair market value on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years.
During the nine months ended October 3, 2021 and September 27, 2020, Teradyne granted 0.3 million and 0.4 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $113.76 and $70.76, respectively, and 0.1 million of service-based restricted stock unit awards to
non-employee
directors at a weighted average grant date fair value of $127.77 and $64.99, respectively.
During the nine months ended October 3, 2021 and September 27, 2020, Teradyne granted 0.1 million of PBIT PRSUs with a grant date fair value of $113.65 and $70.94, respectively.
 
18

During the nine months ended October 3, 2021 and September 27, 2020, Teradyne granted 0.1 million of TSR PRSUs, with a grant date fair value of $125.02 and $89.93, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:
 
 
  
For the Nine Months

Ended
 
  
October 3,
2021
 
September 27,
2020
Risk-free interest rate
     0.2%     1.5%
Teradyne volatility-historical
   43.9%   34.9%
NYSE Composite Index volatility-historical
   22.9%   11.4%
Dividend yield
     0.4%     0.6%
Expected volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $113.48 for the 2021 grant and an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $72.10 for the 2020 grant.
During the nine months ended October 3, 2021 and September 27, 2020, Teradyne granted 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $36.60 and $20.67, respectively.
The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:
 
 
  
For the Nine Months Ended
 
  
October 3,
2021
 
September 27,
2020
Expected life (years)
     5.0     5.0
Risk-free interest rate
   0.4%   1.6%
Volatility-historical
   37.8%   31.6%
Dividend yield
   0.4%   0.6%
Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $113.48 for the 2021 grant and an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $72.10 for the 2020 grant.
 
19

M. ACCUMULATED OTHER COMPREHENSIVE INCOME
Changes in accumulated other comprehensive income, which are presented net of tax, consist of the following:
 
 
  
Foreign

Currency

Translation

Adjustment
 
  
Unrealized

Gains

(Losses) on

Marketable

Securities
 
  
Retirement

Plans
Prior

Service

Credit
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Nine Months Ended October 3, 2021
                                   
Balance at December 31, 2020, net of tax of $0, $1,910, $(1,126), respectively
   $ 25,389      $ 6,954      $ 1,173      $ 33,516  
Other comprehensive loss before reclassifications, net of tax of $0, $(516), $0, respectively
     (26,672      (1,952      —           (28,624
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(186), $(2), respectively
     —           (670      (5      (675
    
 
 
    
 
 
    
 
 
    
 
 
 
Net current period other comprehensive loss, net of tax of $0
, $(702), $
(2), respectively
     (26,672      (2,622      (5      (29,299
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at October 3, 2021, net of tax of $0, $1,208, $(1,128), respectively
   $ (1,283    $ 4,332      $ 1,168      $ 4,217  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Nine Months Ended September 27, 2020
                                   
Balance at December 31, 2019, net of tax of $0, $946, $(1,124), respectively
   $ (23,514    $ 3,480      $ 1,180      $ (18,854
Other comprehensive income before reclassifications, net of tax of $0, $1,410, $0, respectively
     24,131        5,165        —           29,296  
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(615), $
(1
), respectively
     —           (2,188      (6      (2,194
    
 
 
    
 
 
    
 
 
    
 
 
 
Net current period other comprehensive income (loss), net of tax of $0, $795, $(1), respectively
     24,131        2,977        (6      27,102  
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at September 27, 2020, net of tax of $0, $1,741, $(1,125), respectively
   $ 617      $ 6,457      $ 1,174      $ 8,248  
    
 
 
    
 
 
    
 
 
    
 
 
 
Reclassifications out of accumulated other comprehensive income to the statement of operations for the three and nine months ended October 3, 2021 and September 27, 2020 were as follows:
 
Details about Accumulated Other Comprehensive Income Components
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
  
Affected Line Item

in the Statements

of Operations
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
  
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
  
 
 
Available-for-sale
marketable securities:
                                            
Unrealized gains, net of tax of $65, $194, $186, $615, respectively
   $ 229      $ 689      $ 670      $ 2,188        Other (income)
expense, net
 
 
Defined benefit postretirement plan:
                                            
Amortization of prior service credit, net of tax of $0, $0, $2, $1, respectively
     2        2        5        6        (a)  
    
 
 
    
 
 
    
 
 
    
 
 
          
Total reclassifications, net of tax of $65, $194, $188, $616, respectively
   $ 231      $ 691      $ 675      $ 2,194        Net income  
    
 
 
    
 
 
    
 
 
    
 
 
          
 
(a) The amortization of prior service credit is included in the computation of net periodic postretirement benefit cost. See Note Q: “Retirement Plans.”
N. GOODWILL AND ACQUIRED INTANGIBLE ASSETS
Goodwill
Teradyne performs its annual goodwill impairment test as required under the provisions of ASC
350-10,
“Intangibles—Goodwill and Other”
on December 31 of each fiscal year unless interim indicators of impairment exist. Goodwill is considered impaired when the net book value of a reporting unit exceeds its estimated fair value.
 
20

The changes in the carrying amount of goodwill by reportable segments for the nine months ended October 3, 2021, were as follows:
 
 
  
Industrial

Automation
 
 
System
Test
 
 
Wireless
Test
 
 
Semiconductor
Test
 
 
Total
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
(in thousands)
 
Balance at December 31, 2020
                                        
Goodwill
   $ 433,752     $ 158,699     $ 361,819     $ 262,155     $ 1,216,425  
Accumulated impairment losses
     —          (148,183     (353,843     (260,540     (762,566
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
       433,752       10,516       7,976       1,615       453,859  
Foreign currency translation adjustment
     (20,373     —          —          (88     (20,461
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at October 3, 2021
                                        
Goodwill
     413,379       158,699       361,819       262,067       1,195,964  
Accumulated impairment losses
     —          (148,183     (353,843     (260,540     (762,566
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
     $ 413,379     $ 10,516     $ 7,976     $ 1,527     $ 433,398  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Intangible Assets
Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.
Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:
 
 
  
Gross

Carrying

Amount
 
  
Accumulated

Amortization
 
  
Foreign Currency
Translation
Adjustment
 
  
Net

Carrying

Amount
 
 
  
 
 
  
 
 
  
 
 
  
 
 
Balance at October 3, 2021
  
 
(in thousands)
 
                             
Developed technology
   $ 272,547      $ (220,147    $ (3,489    $ 48,911  
Customer relationships
     57,739        (48,351      174        9,562  
Tradenames and trademarks
     70,120        (46,643      (273      23,204  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 400,406      $ (315,141    $ (3,588    $ 81,677  
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, December 31, 2020
                                   
Developed technology
   $ 272,547      $ (210,479    $ (1,610    $ 60,458  
Customer relationships
     66,239        (54,524      305        12,020  
Tradenames and trademarks
     70,120        (42,344      685        28,461  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 408,906      $ (307,347    $ (620    $ 100,939  
    
 
 
    
 
 
    
 
 
    
 
 
 
Aggregate intangible asset amortization expense was $5.4 million and $16.3 million, respectively, for the three and nine months ended October 3, 2021 and $6.2 million and $25.1 million, respectively, for the three and nine months ended September 27, 2020.
Estimated intangible asset amortization expense for each of the five succeeding fiscal years is as follows:
 
Year
  
Amortization Expense
 
 
  
(in thousands)
 
2021 (remainder)
   $ 5,199  
2022
     20,299  
2023
     19,815  
2024
     19,507  
2025
     11,645  
Thereafter
     5,212  
21

O. NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per common share:
 
 
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands, except per share amounts)
 
Net income for basic and diluted net income per share
   $ 256,718      $ 222,718      $ 790,549      $ 587,815  
    
 
 
    
 
 
    
 
 
    
 
 
 
Weighted average common shares-basic
     164,583        166,014        165,690        166,131  
Effect of dilutive potential common shares:
                                   
Convertible note hedge warrant shares (1)
     9,819        7,775        9,774        6,364  
Incremental shares from assumed conversion of convertible notes (2)
     6,464        9,156        8,784        8,029  
Restricted stock units
     1,035        1,237        1,147        1,104  
Stock options
     73        141        87        136  
Employee stock purchase plan
     13        15        10        13  
    
 
 
    
 
 
    
 
 
    
 
 
 
Dilutive potential common shares
     17,404        18,324        19,802        15,646  
    
 
 
    
 
 
    
 
 
    
 
 
 
Weighted average common shares-diluted
     181,987        184,338        185,492        181,777  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net income per common share-basic
   $ 1.56      $ 1.34      $ 4.77      $ 3.54  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net income per common share-diluted
   $ 1.41      $ 1.21      $ 4.26      $ 3.23  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $39.56
 
and $39.58, multiplied by
14.6 
million shares and 14.6 million shares for the three and nine months ended October 3, 2021, respectively. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price of $31.53
 
and $31.54, multiplied by
8.7 
million shares and 11.7 million shares, for the three and nine months ended October 3, 2021, respectively. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.
The computation of diluted net income per common share for the three and nine months ended October 3, 2021 excludes the effect of the potential vesting of 0.1 million and 0.1 million, respectively, of restricted stock units because the effect would have been anti-dilutive.
The computation of diluted net income per common share for the three and nine months ended September 27, 2020 excludes the effect of the potential vesting of 0.1 million and 0.2 million, respectively, of restricted stock units because the effect would have been anti-dilutive.
P. RESTRUCTURING AND OTHER
During the three months ended October 3, 2021, Teradyne recorded $0.6 million of severance charges primarily in Industrial Automation, $0.3 million of acquisition related compensation expenses and $0.3 million for other expenses.
During the three months ended September 27, 2020, Teradyne recorded a $27.2 million gain for the decrease in the fair value of the AutoGuide contingent consideration liability, a $1.1 million gain for the decrease in acquisition related compensation liability, partially offset by $0.5 million recorded for employee severance charges primarily in Industrial Automation.
During the nine months ended October 3, 2021, Teradyne recorded a gain of $7.2 million for the decrease in the fair value of the AutoGuide contingent consideration liability, partially offset by a charge of $1.7 million for an increase in environmental and legal liabilities, $1.2 million of severance charges primarily in Industrial Automation, $0.6 million for other expenses and $0.3 million of acquisition related compensation expenses.
During the nine months ended September 27, 2020, Teradyne recorded a $4.0 million contract termination settlement charge, $3.4 million of acquisition related compensation and expenses, $1.2 million of severance charges primarily in Industrial Automation, and $1.2 million of other expenses, partially offset by a $4.4 million gain for the decrease in the fair value of the AutoGuide contingent consideration liabilities, and a $3.5 million gain for the decrease in the fair value of the MiR contingent consideration liability.
 
22

Q. RETIREMENT PLANS
ASC 715,
“Compensation—Retirement Benefits”
requires an employer with a defined benefit plan or other postretirement benefit plan to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plan. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all of its plans.
Defined Benefit Pension Plans
Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain
non-U.S.
subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of the U.S. qualified pension plan consist primarily of fixed income and equity securities. In addition, Teradyne has unfunded qualified foreign plans as well as an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (“IRC”).
In the nine months ended October 3, 2021, and September 27, 2020, Teradyne contributed $2.5 million and $2.2 million, respectively, to the U.S. supplemental executive defined benefit pension plan and $0.8 million and $0.7 million, respectively, to certain qualified pension plans for
non-U.S.
subsidiaries.
For the three and nine months ended October 3, 2021 and September 27, 2020, Teradyne’s net periodic pension cost was comprised of the following components:
 
 
  
For the Three Months Ended
 
 
  
October 3, 2021
 
  
September 27, 2020
 
 
  
United
  States  
 
  
  Foreign  
 
  
United
  States  
 
  
  Foreign  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Service cost
   $ 452      $ 240      $ 417      $ 216  
Interest cost
     1,098        86        1,460        123  
Expected return on plan assets
     (936      (17      (1,170      (16
Net actuarial loss
     —           —           2,238        —     
Settlement loss
     —           —           450        —     
    
 
 
    
 
 
    
 
 
    
 
 
 
Total net periodic pension cost
   $ 614      $ 309      $ 3,395      $ 323  
    
 
 
    
 
 
    
 
 
    
 
 
 
   
    
For the Nine Months Ended
 
    
October 3, 2021
    
September 27, 2020
 
    
United
  States  
    
  Foreign  
    
United
  States  
    
  Foreign  
 
    
(in thousands)
 
Service cost
   $ 1,357      $ 720      $ 1,283      $ 648  
Interest cost
     3,295        257        4,505        369  
Expected return on plan assets
     (2,809      (50      (3,634      (47
Net actuarial (gain) loss
     (400      —           2,418        —     
Settlement loss
     —           —           450        —     
    
 
 
    
 
 
    
 
 
    
 
 
 
Total net periodic pension cost
   $ 1,443      $ 927      $ 5,022      $ 970  
    
 
 
    
 
 
    
 
 
    
 
 
 
The net periodic pension cost components other than service cost were recorded in other (income) expense, net in the statement of operations.
Postretirement Benefit Plan
In addition to receiving pension benefits, Teradyne employees in the United States who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.
 
23

For the three and nine months ended October 3, 2021 and September 27, 2020, Teradyne’s net periodic postretirement benefit cost (credit) was comprised of the following components:
 
 
  
For the Three

Months

Ended
 
  
For the Nine Months

Ended
 
 
  
October 3,
  2021  
 
  
September 27,
  2020  
 
  
October 3,
  2021  
 
  
September 27,
  2020  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Service cost
   $ 16      $ 14      $ 48      $ 43  
Interest cost
     43        60        128        180  
Amortization of prior service credit
     (2      (2      (7      (7
Net actuarial gain
     —          —          (228      (279
    
 
 
    
 
 
    
 
 
    
 
 
 
Total net periodic postretirement benefit cost (credit)
   $ 57      $ 72      $ (59    $ (63
    
 
 
    
 
 
    
 
 
    
 
 
 
The net periodic postretirement benefit cost (credit) components other than service cost were recorded in other (income) expense, net in the statement of operations.
R. COMMITMENTS AND CONTINGENCIES
Purchase Commitments
As of October 3, 2021, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $811.9 million, of which $777.8 million is for less than one year.
Legal Claims
Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.
On March 8, 2021, Industrial Automation LLC submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand seeks full acceleration of the maximum earnout amount payable under the Purchase Agreement, or $106.9 million, for the alleged breach of the earnout provisions of the Purchase Agreement. On March 26, 2021, Teradyne and AutoGuide filed an answer denying that Teradyne and AutoGuide breached any provisions of the Purchase Agreement. The arbitration hearing is scheduled for March 21, 2022. While it is not possible at this stage to predict the outcome of the arbitration, Teradyne and AutoGuide intend to vigorously defend against the Industrial Automation LLC claims.
S. INCOME TAXES
A reconciliation of the United States federal statutory corporate tax rate to Teradyne’s effective tax rate was as follows:
 
 
  
For the Three
Months

Ended
 
 
For the Nine Months

Ended
 
 
  
October 3,
2021
 
 
September 27,
2020
 
 
October 3,
2021
 
 
September 27,
2020
 
 
  
 
 
 
 
 
 
 
 
 
 
 
                          
U.S. statutory federal tax rate
     21.0     21.0     21.0     21.0
Foreign taxes
     (4.4     (6.9     (4.4     (5.8
Tax credits
     (1.9     (1.6     (1.4     (1.6
International provisions of the U.S. Tax Cuts and Jobs Act of 2017
     (1.5     3.0       (1.6     0.5  
Discrete benefit related to equity compensation
     (0.1     (0.4     (1.6     (1.4
Other, net
     0.7       0.5       0.7       0.6  
    
 
 
   
 
 
   
 
 
   
 
 
 
Effective tax rate
     13.8     15.6     12.7     13.3
    
 
 
   
 
 
   
 
 
   
 
 
 
On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. As of October 3, 2021, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is
more-likely-than-not
that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets.
 
24

As of October 3, 2021, and December 31, 2020, Teradyne had $16.8 million and $17.9 million, respectively, of reserves for uncertain tax positions. The $1.1 million net decrease in reserves for uncertain tax positions is primarily related to U.S. state research and development credits generated in prior years, as well as U.S. federal research and development credits generated in the current year.
As of October 3, 2021, Teradyne estimates that it is reasonably possible that the balance of unrecognized tax benefits may decrease approximately $1.6 million in the next twelve months because of a lapse of statutes of limitation. The estimated decrease relates to loss carryforwards, research credits and U.S. manufacturing activities deductions.
Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of October 3, 2021, and December 31, 2020, $1.5 million and $1.2 million, respectively, of interest and penalties were accrued for uncertain tax positions. For the nine months ended October 3, 2021 and September 27, 2020, expense of $0.3 million and $0.0 million, respectively, was recorded for interest and penalties related to income tax items.
Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the nine months ended October 3, 2021 was $23.9 million, or $0.13 per diluted share. The tax savings due to the tax holiday for the nine months ended September 27, 2020 was $24.9 million, or $0.14 per diluted share. In November 2020, Teradyne entered into an agreement with the Singapore Economic Development Board which extended its Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.
T. SEGMENT INFORMATION
Teradyne has four reportable segments (Semiconductor Test, System Test, Industrial Automation and Wireless Test). Each of the reportable segments is also an individual operating segment.
The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage and system level test, and circuit-board test. The Industrial Automation segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. Each operating segment has a segment manager who is directly accountable to and maintains regular contact with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.
Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments in effect are described in Note B: “Accounting Policies” in Teradyne’s Annual Report on Form
10-K
for the year ended December 31, 2020.
 
25

Segment information for th
e
 three and nine months ended October 3, 2021 and September 27, 2020 is as follows:
 
 
  
Semiconductor

Test
 
  
System

Test
 
  
Industrial

Automation
 
 
Wireless

Test
 
  
Corporate

and

Other
 
 
Consolidated
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
  
(in thousands)
 
             
Three Months Ended October 3, 2021
  
     
  
     
  
     
 
     
  
     
 
     
Revenues
   $ 688,232      $ 102,605      $ 91,014     $ 68,713      $ (63   $ 950,501  
Income (loss) before income taxes (1)(2)
     265,017        31,773        (4,226 )     31,726        (26,535     297,755  
Total assets (3)
     1,251,549        147,970        696,792       119,568        1,546,303       3,762,182  
             
Three Months Ended September 27, 2020
                                                   
Revenues
   $ 592,141      $ 118,169      $ 68,711     $ 40,504      $ (41   $ 819,484  
Income (loss) before income taxes (1)(2)
     189,116        47,368        (5,302     10,938        21,611       263,731  
Total assets (3)
     1,069,830        155,642        667,132       108,671        1,435,237       3,436,512  
             
Nine Months Ended October 3, 2021 (4)
                                                   
Revenues
   $ 2,050,271      $ 340,261      $ 263,151     $ 164,504      $ (352   $ 2,817,835  
Income (loss) before income taxes (1)(2)
     778,687        116,788        (14,586     63,810        (38,925     905,774  
Total assets (3)
     1,251,549        147,970        696,792       119,568        1,546,303       3,762,182  
             
Nine Months Ended September 27, 2020
                                                   
Revenues
   $ 1,735,777      $ 306,051      $ 187,792     $ 133,174      $ (294   $ 2,362,500  
Income (loss) before income taxes (1)(2)
     571,719        114,968        (32,041     35,640        (12,197     678,089  
Total assets (3)
     1,069,830        155,642        667,132       108,671        1,435,237       3,436,512  
 
(1)
Included in Corporate and Other are: contingent consideration adjustments, loss on convertible debt conversions, interest income, interest expense, net foreign exchange gains (losses), pension, intercompany eliminations and acquisition related: (a) charges; (b) legal fees; (c) compensation.
(2)
Included in income (loss) before taxes are charges and credits related to restructuring and other, loss on convertible debt conversions and inventory charges.
(3)
Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities and certain other assets.
(4)
The (loss) before income taxes for the nine months ended October 3, 2021 for Industrial Automation has been decreased and Corporate and Other has been increased to correctly eliminate a
$10.1
million immaterial error in the three and six months ended July 4, 2021 related to intercompany charges. The error is not material to any historical periods.
Included in each segment are charges and credits in the following line items in the statements of operations:
 
 
  
For the Three Months

Ended
 
  
For the Nine Months

Ended
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
October 3,
2021
 
  
September 27,
2020
 
  
October 3,
2021
 
  
September 27,
2020
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Semiconductor Test:
  
     
  
     
  
     
  
     
Cost of revenues—inventory charge
   $ 3,725      $ 1,131      $ 4,959      $ 7,956  
Restructuring and other—Contract termination settlement charge
     —             —          —          4,000  
Industrial Automation:
                                   
Cost of revenues—inventory charge
   $ 3,656      $ —        $ 4,941      $ 505  
Restructuring and other—employee severance
     476        —          965        664  
Restructuring and other—acquisition related expenses and compensation
     —          —          825        790  
Wireless:
                                   
Cost of revenues—inventory charge
   $ 679      $ 1,802      $ 1,351      $ 3,957  
System Test:
                                   
Cost of revenues—inventory charge
   $ —        $ —        $ 524      $ 698  
Corporate and Other:
                                   
Other (income) expense, net—loss on convertible debt conversion
   $ 20,153      $ —        $ 25,397      $ —    
Restructuring and other—other
     —          —          1,846        —    
Restructuring and other—AutoGuide contingent consideration adjustment
     —          (27,206      (7,227      (4,421
Restructuring and other—acquisition related expenses and compensation
     —          (1,086      (513      2,629  
Restructuring and other—MiR contingent consideration adjustment
     —          —          —          (3,546
 
26

U. SHAREHOLDERS’ EQUITY
Stock Repurchase Program
In January 2021, Teradyne’s Board of Directors cancelled the January 2020 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. Teradyne intends to repurchase a minimum of $600 million in 2021.
During the nine months ended October 3, 2021, Teradyne repurchased 3.3 million shares of common stock for $406.2 million at an average price of $123.53 per share. During the nine months ended September 27, 2020, Teradyne repurchased 1.5 million shares of common stock for $88.5 million at an average price of $58.33 per share.
The total price includes commissions and is recorded as a reduction to retained earnings.
Dividend
Holders of Teradyne’s common stock are entitled to receive dividends when they are declared by Teradyne’s Board of Directors.
In January 2021, May 2021 and August 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three and nine months ended October 3, 2021 were $16.4 million and $49.7 million, respectively.
In January 2020, May 2020 and August 2020, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three and nine months ended September 27, 2020 were $16.6 million and $49.9 million, respectively.
While Teradyne declared a quarterly cash dividend and authorized a share repurchase program, it may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradyne’s Board of Directors, which will consider, among other things, Teradyne’s earnings, capital requirements and financial condition.
 
27

Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Statements in this Quarterly Report on Form
10-Q
which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form
10-Q
and Part I, Item 1A “Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2020. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are a leading global supplier of automation equipment for test and industrial applications. We design, develop, manufacture and sell automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our industrial automation products include collaborative robotic arms, autonomous mobile robots (“AMRs”) and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automatic test equipment and industrial automation products and services include:
 
   
semiconductor test (“Semiconductor Test”) systems;
 
   
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
 
   
wireless test (“Wireless Test”) systems; and
 
   
industrial automation (“Industrial Automation”) products.
The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our test products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.
Industrial Automation segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial applications and AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs. The market for our industrial automation segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (SMEs) throughout the world.
Our strategy is to focus on profitably growing market share in our test businesses, the introduction of differentiated products that target growth segments, and accelerating growth through continued investment in our Industrial Automation businesses. We plan to execute on our strategy while balancing capital allocations between returning capital to our shareholders through dividends and stock repurchases and using capital for opportunistic acquisitions.
Impact of the
COVID-19
Pandemic on our Business
The novel coronavirus
(COVID-19)
pandemic resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines,
shelter-in-place
orders, vaccine and testing mandates, and business limitations and shutdowns. These measures have impacted our
day-to-day
operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. We are continuing to monitor the rapidly evolving situation regarding the
COVID-19
pandemic and the availability and impact of vaccinations globally. However, we are unable to accurately predict the full impact of
COVID-19,
which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges in areas where we do business, the availability of vaccinations, any further government actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.
 
28

Table of Contents
Health and Safety
In response to the
COVID-19
pandemic, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, contract manufacturers and suppliers and we have complied with all government orders around the globe. The spread of COVID- 19 has caused us to modify our business practices, including implementing vaccination, testing, masking and social distancing policies, suspending employee travel, requiring most employees to work remotely, cancelling physical participation in meetings, and extensively and frequently disinfecting our workspaces. Around the world, many of our employees are working from home. However, some of our engineering, operations, supply line and customer support teams must be
on-site
at our or our customers’ facilities. We are providing those
on-site
employees with the necessary protective resources and procedures to minimize their exposure risk. We may take further actions as may be required or recommended by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers.
Operations
We believe the
COVID-19
pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our third quarter of 2021 financial results or to our future financial results. In addition, the pandemic has disrupted our contract manufacturers and suppliers, and has resulted in some instances in short-term cost increases to meet customer demand. While the duration and severity of the pandemic may further impact our workforce and operations, as well as those of our customers, contract manufacturers and suppliers, we expect that our manufacturing facilities will remain operational, at sufficient capacity to support production demand. We are monitoring our operations closely in an effort to avoid any potential productivity loss caused by responses to the
COVID-19
pandemic.
Supply
We have experienced interruptions to our supply chain as a result of the
COVID-19
pandemic. Our suppliers have faced and may continue to face difficulties maintaining operations in light of
COVID-19
disruptions and government-ordered restrictions. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles caused by the pandemic. There is no assurance that these efforts will be successful. The
COVID-19
pandemic may continue to disrupt our ability to obtain components required to manufacture our products, adversely affecting our operations and in some instances resulting in higher costs and delays, both for obtaining components and shipping finished goods to customers. The interruptions to our supply chain caused by the
COVID-19
pandemic impacted our financial results in the quarter, particularly for our Industrial Automation businesses, and may continue to impact our business, revenue, and profitability.
Demand
The
COVID-19
pandemic has significantly increased economic uncertainty in our markets. Demand for our Test products was strong throughout 2020 and in the first nine months of 2021. Our Industrial Automation business, however, experienced a significant decline in demand through the first half of 2020 due to
COVID-19
related shutdowns affecting global manufacturing but demand recovered in the second half of 2020 from the low point in the second quarter and continued to recover in the first nine months of 2021. The
COVID-19
pandemic could cause further global economic disruption that could cause demand for our products to decline, which would adversely affect our business.
Liquidity
Although there is continued uncertainty related to the impact of the
COVID-19
pandemic on our future results, we believe our business model and our current cash reserves leave us well-positioned to manage our business through this crisis. We have a strong balance sheet as well as an operating model that we believe is capable of flexing up and down with extreme demand swings while still remaining profitable. Based on our analysis, we believe our existing balances of cash and cash equivalents and our currently anticipated operating cash flows will be sufficient to meet our working capital needs and other capital and liquidity requirements for the next twelve months. However, due to the uncertainty related to the future impact of the
COVID-19
pandemic, in order to bolster our liquidity position, on May 1, 2020 we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million as further described in Note H: “Debt.” As of November 5, 2021, we have not borrowed any funds under the credit facility.
We are continuing to monitor the evolving situation regarding the
COVID-19
pandemic, the availability of vaccinations where we do business and guidance from government authorities around the world. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As a result, given the uncertain nature of this situation, we are not able to accurately predict the full extent of the impact of
COVID-19
on our business, financial condition, results of operations, liquidity, or cash flows in the future. In addition, see Part II—Item 1A, “Risk Factors,” included in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2020 for our risk factors regarding risks associated with the
COVID-19
pandemic.
 
29

Table of Contents
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the nine months ended October 3, 2021 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2020.
Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of November 5, 2021, the date of issuance of this Quarterly Report on Form
10-Q.
These estimates may change, as new events occur, and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates under different assumptions or conditions.
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
 
    
For the Three Months

Ended
   
For the Nine Months

Ended
 
    
October 3,
   
September 27,
   
October 3,
   
September 27,
 
    
2021
   
2020
   
2021
   
2020
 
                          
Percentage of revenues:
        
Revenues:
        
Products
     87     85     87     86
Services
     13       15       13       14  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total revenues
     100       100       100       100  
Cost of revenues:
        
Cost of products
     35       37       35       37  
Cost of services
     5       7       5       6  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)
     40       44       40       43  
  
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     60       56       60       57  
Operating expenses:
        
Selling and administrative
     14       14       14       14  
Engineering and development
     11       12       11       12  
Acquired intangible assets amortization
     1       1       1       1  
Restructuring and other
     —         (3     —         —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     26       23       26       27  
  
 
 
   
 
 
   
 
 
   
 
 
 
Income from operations
     34       33       34       29  
Non-operating
(income) expense:
        
Interest income
     —         —         —         —    
Interest expense
     —         1       1       1  
Other (income) expense, net
     2       —         1       —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Income before income taxes
     31       32       32       29  
Income tax provision
     4       5       4       4  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net income
     27     27     28     25
  
 
 
   
 
 
   
 
 
   
 
 
 
 
30

Table of Contents
Results of Operations
Third Quarter 2021 Compared to Third Quarter 2020
Revenues
Revenues by our reportable segments were as follows:
 
    
For the Three Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
2021
    
2020
    
Change
 
                      
    
(in millions)
 
Semiconductor Test
   $ 688.2      $ 592.1      $ 96.1  
System Test
     102.6        118.2        (15.6
Industrial Automation
     91.0        68.7        22.3  
Wireless Test
     68.7        40.5        28.2  
Corporate and Other
     (0.1      —          (0.1
  
 
 
    
 
 
    
 
 
 
   $ 950.5      $ 819.5      $ 131.0  
  
 
 
    
 
 
    
 
 
 
The increase in Semiconductor Test revenues of $96.1 million, or 16.2%, was driven primarily by greater tester sales driven by testing of mobile application processors and industrial and automotive devices, partially offset by a decrease in tester sales for high performance compute processors and lower memory test sales of DRAM memory testers. The decrease in System Test revenues of $15.6 million, or 13.2%, was primarily due to lower sales in Storage Test of hard disk drive testers, partially offset by greater sales in Production Board Test, due to higher automotive electronics demand. The increase in Industrial Automation revenues of $22.3 million, or 32.5%, was driven by demand for collaborative robotic arms. The rise in Wireless Test revenues of $28.2 million, or 69.6%, was primarily due to an increase in WiFi tester sales, including our new WiFi 7 product, and higher demand in the ultra-wide band wireless test market.
Revenues by country as a percentage of total revenues were as follows (1):
 
    
For the Three Months

Ended
 
    
October 3,
   
September 27,
 
    
2021
   
2020
 
              
Taiwan
     27     37
China
     19       15  
United States
     11       10  
Korea
     8       16  
Europe
     8       6  
Malaysia
     6       2  
Japan
     5       2  
Singapore
     5       2  
Philippines
     5       2  
Thailand
     3       5  
Rest of World
     3       3  
  
 
 
   
 
 
 
     100     100
  
 
 
   
 
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.
 
31

Table of Contents
Gross Profit
Our gross profit was as follows:
 
    
For the Three Months

Ended
       
    
October 3,
   
September 27,
   
Dollar/Point
 
    
2021
   
2020
   
Change
 
                    
    
(in millions)
 
Gross profit
   $ 571.0     $ 458.9     $ 112.1  
Percent of total revenues
     60.1     56.0     4.1  
Gross profit as a percent of revenue increased by 4.1 points, primarily due to product mix of higher margin products in Semiconductor Test and operating leverage due to higher revenues.
Selling and Administrative
Selling and administrative expenses were as follows:
 
    
For the Three Months

Ended
       
    
October 3,
   
September 27,
   
Dollar
 
    
2021
   
2020
   
    Change    
 
                    
    
(in millions)
 
Selling and administrative
   $ 134.8     $ 115.8     $ 19.0  
Percent of total revenues
     14.2     14.1  
The increase of $19.0 million in selling and administrative expenses was primarily due to higher variable compensation, and greater selling and administrative spending across all segments.
Engineering and Development
Engineering and development expenses were as follows:
 
    
For the Three Months

Ended
       
    
October 3,
   
September 27,
   
    Dollar    
 
    
2021
   
2020
   
Change
 
                    
    
(in millions)
 
Engineering and development
   $ 107.2     $ 94.9     $ 12.3  
Percent of total revenues
     11.3     11.6  
The increase of $12.3 million in engineering and development expenses was primarily due to higher spending across all segments and higher variable compensation.
Restructuring and Other
During the three months ended October 3, 2021, we recorded $0.6 million of severance charges primarily in Industrial Automation, $0.3 million of acquisition related compensation expenses and $0.3 million for other expenses.
During the three months ended September 27, 2020, we recorded a $27.2 million gain for the decrease in the fair value of the AutoGuide contingent consideration liability, and a $1.1 million gain for the decrease in acquisition related compensation liability, partially offset by $0.5 million recorded for employee severance charges primarily in Industrial Automation.
 
32

Table of Contents
Interest and Other
 
    
For the Three Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
        2021        
    
        2020        
    
        Change        
 
                      
    
(in millions)
 
Interest income
   $ (0.6    $ (1.1    $ 0.5  
Interest expense
     3.8        6.2      $ (2.4
Other (income) expense, net
     21.5        0.8      $ 20.7  
Interest income decreased by $0.5 million primarily due to lower interest rates in 2021 compared to 2020. Interest expense decreased by $2.4 million primarily due to lower convertible debt interest expenses, as a result of early conversions in 2021. Other (income) expense, rose by $20.7 million primarily due to $20.2 million losses on convertible debt conversions in 2021.
Income (Loss) Before Income Taxes
 
    
For the Three Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
        2021        
    
        2020        
    
        Change        
 
                      
    
(in millions)
 
Semiconductor Test
   $ 265.0      $ 189.1      $ 75.9  
System Test
     31.8        47.4        (15.6
Wireless Test
     31.7        10.9        20.8  
Industrial Automation
     (4.2      (5.3      1.1  
Corporate and Other (1)
     (26.5      21.6        (48.1
  
 
 
    
 
 
    
 
 
 
   $ 297.8      $ 263.7      $ 34.1  
  
 
 
    
 
 
    
 
 
 
 
(1)
Included in Corporate and Other are: contingent consideration adjustments, loss on convertible debt conversions, interest income, interest expense, net foreign exchange gains (losses), pension, intercompany eliminations and acquisition related: (a) charges; (b) legal fees; (c) compensation.
The increase in income before income taxes in Semiconductor Test was driven by testing of mobile application processors and industrial and automotive devices, partially offset by a decrease in tester sales for high performance compute processors and lower memory test sales of DRAM memory testers. The decrease in income before income taxes in System Test was primarily due to lower sales in Storage Test of hard disk drive testers, partially offset by greater sales in Production Board Test, due to higher automotive electronics demand. The increase in income before income taxes in Wireless Test was primarily due to growth in WiFi tester sales, including our new WiFi 7 product, and greater demand in the ultra-wide band wireless test market. The decrease in income (loss) before income taxes in Corporate and Other was primarily due to a gain for the decrease in the fair value of the AutoGuide contingent consideration liability in 2020 and losses on convertible debt conversions in 2021.
Income Taxes
The effective tax rate for the three months ended October 3, 2021 and September 27, 2020 was 13.8% and 15.6%, respectively. The decrease in the effective tax rate from the three months ended September 27, 2020 to the three months ended October 3, 2021 was primarily attributable to an increase in benefit from the international provisions of the U.S. Tax Cuts and Jobs Act of 2017 and an increase in benefit from tax credits partially offset by a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions and a decrease in discrete benefit related to equity compensation.
 
33

Table of Contents
Nine Months 2021 Compared to Nine Months 2020
Revenues
Revenues by our four reportable segments were as follows:
 
    
For the Nine Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
        2021        
    
        2020        
    
        Change        
 
                      
    
(in millions)
 
Semiconductor Test
   $ 2,050.3      $ 1,735.8      $ 314.5  
System Test
     340.3        306.1        34.2  
Industrial Automation
     263.2        187.8        75.4  
Wireless Test
     164.5        133.2        31.3  
Corporate and Other
     (0.4      (0.3      (0.1
  
 
 
    
 
 
    
 
 
 
   $ 2,817.8      $ 2,362.5      $ 455.3  
  
 
 
    
 
 
    
 
 
 
The increase in Semiconductor Test revenues of $314.5 million, or 18.1%, was driven primarily by incremental tester sales driven by testing of high performance compute processors, automotive and industrial devices, and higher service, partially offset by lower mobile application processor testers. The rise in System Test revenues of $34.2 million, or 11.2%, was primarily due to elevated sales in Storage Test of system level testers, and greater sales in Production Board Test due to higher automotive electronics demand. The growth in Industrial Automation revenues of $75.4 million, or 40.1%, was driven by demand for collaborative robotic arms. The increase in Wireless Test revenues of $31.3 million, or 23.5%, was primarily due to greater sales in connectivity test products.
Revenues by country as a percentage of total revenues were as follows (1):
 
    
For the Nine Months

Ended
 
    
October 3,
   
September 27,
 
    
2021
   
2020
 
              
Taiwan
     36     40
China
     18       15  
United States
     10       9  
Korea
     8       12  
Europe
     7       6  
Philippines
     5       2  
Japan
     4       5  
Thailand
     4       4  
Malaysia
     4       2  
Singapore
     3       2  
Rest of World
     1       3  
  
 
 
   
 
 
 
     100     100
  
 
 
   
 
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.
Gross Profit
Our gross profit was as follows:
 
    
For the Nine Months

Ended
       
    
October 3,
   
September 27,
   
Dollar/Point
 
    
        2021        
   
        2020        
   
        Change        
 
                    
    
(in millions)
 
Gross profit
   $ 1,679.6     $ 1,336.0     $ 343.6  
Percent of total revenues
     59.6     56.5     3.1  
 
34

Table of Contents
Gross profit as a percent of revenue increased by 3.1 points, primarily due to product mix of higher margin products in Semiconductor Test and operating leverage due to higher revenues.
Selling and Administrative
Selling and administrative expenses were as follows:
 
    
For the Nine Months

Ended
       
    
October 3,
   
September 27,
   
Dollar
 
    
        2021        
   
        2020        
   
        Change        
 
                    
    
(in millions)
 
Selling and administrative
   $ 404.8     $ 340.5     $ 64.3  
Percent of total revenues
     14.4     14.4  
The increase of $64.3 million in selling and administrative expenses was primarily due to higher variable compensation and higher selling spending across all segments.
Engineering and Development
Engineering and development expenses were as follows:
 
    
For the Nine Months

Ended
       
    
October 3,
   
September 27,
   
Dollar
 
    
        2021        
   
        2020        
   
        Change        
 
                    
    
(in millions)
 
Engineering and development
   $ 317.6     $ 274.2     $ 43.4  
Percent of total revenues
     11.3     11.6  
The increase of $43.4 million in engineering and development expenses was primarily due to higher spending across all segments and higher variable compensation.
Restructuring and Other
During the nine months ended October 3, 2021, we recorded a gain of $7.2 million for the decrease in the fair value of the AutoGuide contingent consideration liability, partially offset by a charge of $1.7 million for an increase in environmental and legal liabilities, $1.2 million of severance charges primarily in Industrial Automation, $0.6 million for other expenses and $0.3 million of acquisition related compensation expenses.
During the nine months ended September 27, 2020, we recorded a $4.0 million contract termination settlement charge, $3.4 million of acquisition related compensation and expenses, $1.2 million of severance charges primarily in Industrial Automation, and $1.2 million of other expenses, partially offset by a $4.4 million gain for the decrease in the fair value of the AutoGuide contingent consideration liabilities, and a $3.5 million gain for the decrease in the fair value of the MiR contingent consideration liability.
Interest and Other
 
    
For the Nine Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
        2021        
    
        2020        
    
        Change        
 
                      
    
(in millions)
 
Interest income
   $ (2.1    $ (5.2    $ 3.1  
Interest expense
     15.4        17.8        (2.4
Other (income) expense, net
     25.2        3.6        21.6  
Interest income decreased by $3.1 million primarily due to lower interest rates and a lower marketable securities balance in 2021 compared to 2020. Interest expense decreased by $2.4 million primarily due to lower convertible debt interest expense due to early conversions in 2021. Other (income) expense, net increased by $21.6 million primarily due to $25.4 million losses on convertible debt conversions in 2021, partially offset by the change in unrealized gains/losses on equity securities, from losses in 2020 to gains in 2021 and the change in pension actuarial gains/losses, from losses in 2020 to gains in 2021.
 
35

Table of Contents
Income (Loss) Before Income Taxes
 
    
For the Nine Months

Ended
        
    
October 3,
    
September 27,
    
Dollar
 
    
        2021        
    
        2020        
    
        Change        
 
                      
    
(in millions)
 
Semiconductor Test
   $ 778.7      $ 571.7      $ 207.0  
System Test
     116.8        115.0        1.8  
Wireless Test
     63.8        35.6        28.2  
Industrial Automation
     (14.6      (32.0      17.4  
Corporate and Other (1)
     (38.9      (12.2      (26.7
  
 
 
    
 
 
    
 
 
 
   $ 905.8      $ 678.1      $ 227.7  
  
 
 
    
 
 
    
 
 
 
 
(1)
Included in Corporate and Other are contingent consideration adjustments, loss on convertible debt conversions, interest income, interest expense, net foreign exchange gains (losses), pension, intercompany eliminations, and acquisition related: (a) charges; (b) legal fees; (c) compensation.
The increase in income before income taxes in Semiconductor Test was driven primarily by an increase in tester sales driven by testing of high performance compute processors, automotive and industrial devices, and service, partially offset by lower mobile applications processor testers. The improvement in income before income taxes in System Test was primarily due to elevated sales in Storage Test of system level testers, and greater sales in Production Board Test due to higher automotive electronics demand. The increase in income before income taxes in Wireless Test was primarily due to higher sales in connectivity test products. The decrease in loss before income taxes in Industrial Automation was primarily due to higher sales and lower intangible assets amortization expense. The loss before income taxes in Corporate and Other was primarily due to losses on convertible debt conversions in 2021.
Income Taxes
The effective tax rate for the nine months ended October 3, 2021 and September 27, 2020 was 12.7% and 13.3%, respectively. The decrease in the effective tax rate from the nine months ended September 27, 2020 to the nine months ended October 3, 2021 was primarily attributable to an increase in benefits from the international provisions of the U.S. Tax Cuts and Jobs Act of 2017 and an increase in discrete benefits related to equity compensation partially offset by a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions, and a reduction in benefits from tax credits.
Contractual Obligations
There have been no changes outside of the ordinary course of business to our contractual obligations as disclosed in our Annual Report on Form
10-K
for the year ended December 31, 2020.
Liquidity and Capital Resources
Our cash, cash equivalents, and marketable securities balances decreased by $104.9 million in the nine months ended October 3, 2021 to $1,449.5 million.
Operating activities during the nine months ended October 3, 2021 provided cash of $767.1 million. Changes in operating assets and liabilities used cash of $167.7 million. This was due to a $219.9 million increase in operating assets and a $52.2 million increase in operating liabilities.
The increase in operating assets was due to a $138.6 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $103.3 million increase in accounts receivable due to greater sales, partially offset by a $21.9 million decrease in inventories.
The change in operating liabilities was due to increases of $63.5 million in other accrued liabilities, $23.8 million in accounts payable, and $8.7 million in deferred revenue and customer advance payments, partially offset by a $17.4 million decrease in income taxes, a $22.3 million decrease in accrued employee compensation, and $4.1 million of retirement plan contributions.
 
36

Table of Contents
Investing activities during the nine months ended October 3, 2021 provided cash of $156.1 million due to $571.3 million and $209.4 million in proceeds from maturities and sales of marketable securities, partially offset by $509.5 million used for purchases of marketable securities, $103.2 million used for purchases of property, plant and equipment and $12.0 million used for an investment in MachineMetrics, Inc.(“MachineMetrics”).
Financing activities during the nine months ended October 3, 2021 used cash of $757.3 million due to $406.2 million used for the repurchase of 3.3 million shares of common stock at an average price of $123.53 per share, $302.0 million used for payments of convertible debt principal, $49.7 million used for dividend payments, and $32.0 million used for payments related to net settlements of employee stock compensation awards, partially offset by $32.6 million from the issuance of common stock under employee stock purchase and stock option plans.
Operating activities during the nine months ended September 27, 2020 provided cash of $608.5 million. Changes in operating assets and liabilities used cash of $107.4 million. This was due to a $245.8 million increase in operating assets and a $138.3 million increase in operating liabilities.
The increase in operating assets was due to a $222.0 million increase in accounts receivable due to increased sales, a $40.8 million increase in prepayments and other assets, partially offset by a $17.0 million decrease in inventories.
The increase in operating liabilities was due to a $47.3 million increase in other accrued liabilities, a $36.6 million increase in deferred revenue and customer advance payments, a $24.1 million increase in income taxes, a $23.8 million increase in accounts payable, and a $10.5 million increase in accrued employee compensation, partially offset by $3.9 million of retirement plan contributions.
Investing activities during the nine months ended September 27, 2020 used cash of $292.6 million, due to $488.4 million used for purchases of marketable securities, and $146.9 million used for purchases of property, plant and equipment, partially offset by $309.4 million and $32.6 million in proceeds from maturities and sales of marketable securities, respectively, and proceeds from life insurance of $0.5 million related to the cash surrender value from the cancellation of a Teradyne owned life insurance policy.
Financing activities during the nine months ended September 27, 2020 used cash of $143.4 million, due to $88.5 million used for the repurchase of 1.5 million shares of common stock at an average price of $58.33 per share, $49.9 million used for dividend payments, $22.7 million used for payments related to net settlements of employee stock compensation awards, and $8.9 million used for a payment related to MiR acquisition contingent consideration, partially offset by $26.5 million from the issuance of common stock under employee stock purchase and stock option plans.
In January 2021, May 2021 and August 2021, our Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the nine months ended October 3, 2021 were $49.7 million.
In January 2020, May 2020 and August 2020, our Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the nine months ended September 27, 2020 were $49.9 million.
In January 2021, our Board of Directors cancelled the January 2020 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. Unless terminated by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program. We intend to repurchase a minimum of $600 million in 2021.
During the nine months ended October 3, 2021, we repurchased 3.3 million shares of common stock for $406.2 million at an average price of $123.53 per share. During the nine months ended September 27, 2020, we repurchased 1.5 million shares of common stock for $88.5 million at an average price of $58.33 per share.
While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.
On May 1, 2020, we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million. As of November 5, 2021, we have not borrowed any funds under the credit facility.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the
COVID-19
pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.
 
37

Table of Contents
Equity Compensation Plans
As discussed in Note Q: “Stock-Based Compensation” in our 2020 Annual Report on Form
10-K,
we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).
The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.
Recently Issued Accounting Pronouncements
In August 2020, the FASB issued ASU
2020-06
– “Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,” which simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. This ASU requires a convertible debt instrument to be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. This ASU requires an entity to use the
if-converted
method in the diluted earnings per share calculation for convertible instruments. This ASU will be effective for Teradyne on January 1, 2022. This ASU permits the use of either the modified retrospective or fully retrospective method of transition. We are evaluating the effects of the adoption of this ASU on our financial statements.
On November 4, 2021, we made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash. Upon adoption of ASU
2020-06
only the amounts settled in excess of the principal will be considered in diluted earnings per share under the
if-converted
method.
 
Item 3:
Quantitative and Qualitative Disclosures about Market Risks
For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form
10-K
filed with the SEC on February 22, 2021. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2020.
In addition to market risks described in our Annual Report on Form
10-K,
we have an equity price risk related to the fair value of our convertible senior unsecured notes issued in December 2016. In December 2016, Teradyne issued $460 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023. As of October 3, 2021, $158.0 million of principal remained outstanding and the Notes had a fair value of $546.5 million. The table below provides a sensitivity analysis of hypothetical 10% changes of Teradyne’s stock price as of the end of the third quarter of 2021 and the estimated impact on the fair value of the Notes. The selected scenarios are not predictions of future events, but rather are intended to illustrate the effect such event may have on the fair value of the Notes. The fair value of the Notes is subject to equity price risk due to the convertible feature. The fair value of the Notes will generally increase as Teradyne’s common stock price increases and will generally decrease as the common stock price declines in value. The change in stock price affects the fair value of the Notes, but does not impact Teradyne’s financial position, cash flows or results of operations due to the fixed nature of the debt obligation. Additionally, we carry the Notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only. In connection with the offering of the Notes we also sold warrants to the option counterparties. These transactions have been accounted for as an adjustment to our shareholders’ equity. The convertible note hedge transactions are expected to reduce the potential equity dilution upon conversion of the Notes. The warrants along with any shares issuable upon conversion of the Notes will have a dilutive effect on our earnings per share to the extent that the average market price of our common stock for a given reporting period exceeds the applicable strike price or conversion price of the warrants or Notes, respectively.
 
Hypothetical Change in Teradyne Stock Price
  
Fair Value
    
Estimated change
in fair value
    
Hypothetical
percentage
increase (decrease)
in fair value
 
                      
10% Increase
   $ 601,331      $ 54,867        10.0
No Change
     546,464        —          —    
10% Decrease
     491,600        (54,864      (10.0
 
38

Table of Contents
Item 4:
Controls and Procedures
As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule
13a-15(b)
or Rule
15d-15(b)
promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
There have been no changes in our internal control over financial reporting (as defined in Rules
13a-15(f)
and
15d-15(f)
under the Exchange Act) during the three months ended October 3, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
 
Item 1:
Legal Proceedings
We are subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. We believe that we have meritorious defenses against all pending claims and intend to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, we believe the potential losses associated with all of these actions are unlikely to have a material adverse effect on our business, financial position or results of operations.
On March 8, 2021, Industrial Automation LLC submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand seeks full acceleration of the maximum earnout amount payable under the Purchase Agreement, or $106.9 million, for the alleged breach of the earnout provisions of the Purchase Agreement. On March 26, 2021, Teradyne and AutoGuide filed an answer denying that Teradyne and AutoGuide breached any provisions of the Purchase Agreement. The arbitration hearing is scheduled for March 21, 2022. While it is not possible at this stage to predict the outcome of the arbitration, Teradyne and AutoGuide intend to vigorously defend against the Industrial Automation LLC claims.
 
Item 1A:
Risk Factors
In addition to other information set forth in this Form
10-Q,
including the risk discussed below, you should carefully consider the factors discussed in Part I, “Item 1A: Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2020, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form
10-K
remain applicable to our business and many of these risks could be further increased due to the
COVID-19
pandemic.
The risks described in our Annual Report on Form
10-K
are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
The global supply shortage of electrical components may impact our ability to meet customer demand.
There is currently a global supply shortage of electrical components, including semiconductor chips. As a result, we have experienced increases in our lead times and costs for certain components for certain products and delays in the delivery of some orders placed by our customers. At this time, these supply chain challenges have not had a material impact on our business, results of operations or financial condition. However, if we are unable to secure manufacturing capacities from our current suppliers and contract manufacturers, our ability to deliver our products to our customers may be negatively impacted. Also, our suppliers and contract manufacturers may increase their fees, which would result in an increase in our manufacturing costs, which we may not be fully able to pass to our customers, which could have a negative impact on our results of operations and financial condition. Additionally, if any of our suppliers and contract manufacturers were to cancel contracts or commitments or fail to meet the quality or delivery requirements needed to satisfy customer orders for our products, we could lose time-sensitive customer orders, have significantly decreased revenues and earnings and be subject to contractual penalties, which would have a material adverse effect on our business, results of operations and financial condition.
 
39

Table of Contents
The novel coronavirus
(COVID-19)
pandemic has impacted our business and could materially adversely affect our results of operations, financial condition, liquidity or cash flows.
The global pandemic of the novel strain of the coronavirus
(COVID-19)
has resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines,
shelter-in-place
orders, vaccination and testing mandates, and business limitations and shutdowns. These measures have impacted our
day-to-day
operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. Most recently, on September 9, 2021, President Biden issued Executive Order 14042 requiring covered employees of certain Federal contractors and subcontractors to be “fully vaccinated,” unless legally entitled to an accommodation due to a disability or religious belief, practice, or observance. Additionally, on September 9, 2021, President Biden announced that he has directed the Occupational Safety and Health Administration (OSHA) to develop a rule mandating vaccination or weekly testing for employers with 100+ employees. As Teradyne implements measures to comply with these new regulations, the Company may experience increased compliance costs, increased risk of
non-compliance
and increased risk of employee attrition. The
COVID-19
pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including increasing costs company-wide, but we cannot accurately estimate the full extent of the impact for our 2021 financial results or to our future financial results.
The
COVID-19
pandemic has significantly increased economic and demand uncertainty in our markets. The uncertainty resulted in a significant decrease in demand for certain of our products and could continue to impact demand for an uncertain period of time. The spread of
COVID-19
has caused us to modify our business practices, including implementing vaccination, testing, masking and social distancing policies, suspending employee travel, requiring most employees to work remotely, canceling physical participation in meetings, events and conferences, and extensively and frequently disinfecting our workspaces, and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers.
We are continuing to monitor the rapidly evolving situation regarding the
COVID-19
pandemic and the availability of vaccinations where we do business. However, we are unable to accurately predict the full impact of
COVID-19,
which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges of the virus, the availability of vaccines, further government actions to contain the virus, and how quickly and to what extent normal economic and operating conditions can resume.
 
Item 2:
Unregistered Sales of Equity Securities and Use of Proceeds
In January 2020, Teradyne’s Board of Directors authorized a new stock repurchase program for up to $1.0 billion of common stock. Effective April 1, 2020, Teradyne suspended its share repurchase program. In January 2021, Teradyne’s Board of Directors cancelled the January 2020 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. During the nine months ended October 3, 2021, we repurchased 3.3 million shares of common stock for $406.2 million at an average price of $123.53 per share. During the nine months ended September 27, 2020, we repurchased 1.5 million shares of common stock for $88.5 million at an average price of $58.33 per share.
The following table includes information with respect to repurchases we made of our common stock during the three months ended October 3, 2021 (in thousands except per share price):
 
Period
  
(a) Total

Number of

Shares

(or Units)

Purchased
          
(b) Average

Price Paid per

Share (or Unit)
          
(c) Total Number of

Shares (or Units)

Purchased as Part of

Publicly Announced

Plans or Programs
    
(d) Maximum Number

(or Approximate Dollar

Value) of Shares (or

Units) that may Yet Be

Purchased Under the

Plans or Programs
 
July 5, 2021 - August 1, 2021
     501        $ 125.31          500      $ 1,740,717  
August 2, 2021 – August 29, 2021
     545          121.08          545        1,674,719  
August 30, 2021 – October 3, 2021
     679          119.22          679        1,593,820  
  
 
 
      
 
 
      
 
 
    
     1,725        (1   $ 121.58        (1     1,724     
  
 
 
      
 
 
      
 
 
    
 
(1)
Includes approximately two thousand shares at an average price of $125.40 withheld from employees for the payment of taxes.
We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.
 
40

Table of Contents
Item 4:
Mine Safety Disclosures
Not Applicable
 
41

Table of Contents
Item 6:
Exhibits
 
Exhibit
Number
  
Description
    4.1    First Supplemental Indenture dated as of November 4, 2021 between Teradyne Inc. and Wilmington Trust, National Association, as trustee (filed herewith)
  10.1    Deferral Plan for Non-Employee Directors, as amended (filed herewith)*
  31.1    Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
  31.2    Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
  32.1    Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
  32.2    Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
101.INS    XBRL Instance Document
101.SCH    XBRL Taxonomy Extension Schema Document
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    XBRL Taxonomy Extension Label Linkbase Document
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL, and contained in Exhibit 101)
 
*
Management Contract or Compensatory Plan
 
42

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
TERADYNE, INC.
Registrant
/
S
/ S
ANJAY
M
EHTA
Sanjay Mehta
Vice President,
Chief Financial Officer and Treasurer
(Duly Authorized Officer
and Principal Financial Officer)
November 5, 2021
 
43